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Summary of findings {#CD008736-sec1-0001}
===================

Summary of findings for the main comparisonSummary of findings table 1**Indoor residual spraying (IRS) versus no intervention for preventing leishmaniasisPatient or population:** People at risk of cutaneous leishmaniasis (CL) or visceral leishmaniasis (VL)\
**Settings:** CL or VL endemic areas\
**Intervention:** IRS\
**Comparison:** No intervention**OutcomesIllustrative comparative risks\* (95% CI)Relative effect (95% CI)No of participants (trials)Quality of the evidence (GRADE)CommentsAssumed riskCorresponding riskNo interventionIRSVector density**‐‐Not pooled(4 trials)⊕⊕⊕⊝ **moderate**^1,2,3^Reductions in sandfly abundance were seen after IRS spraying in all four trials**CL cases**\
\> 12 months follow‐up**52 per 100032 per 1000**\
(20 to 50)**RR 0.61**\
(0.38 to 0.97)**2892**\
(1 trial)⊕⊕⊕⊝ **moderate**^1,4,5,6^‐**VL cases**\
\> 2 years follow‐up‐‐‐(0 trials)‐‐\*The basis for the **assumed risk** (for example, the median control group risk across trials) is provided in footnotes. The **corresponding risk** (and its 95% CI) is based on the assumed risk in the comparison group and the **relative effect** of the intervention (and its 95% CI). **CI:** confidence interval; **RR:** risk ratio; **CL:** cutaneous leishmaniasis; **VL:** visceral leishmaniasis; **IRS:** indoor residual spraying.GRADE Working Group grades of evidence **High quality:** Further research is very unlikely to change our confidence in the estimate of effect. **Moderate quality:** Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. **Low quality:** Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. **Very low quality:** We are very uncertain about the estimate.[^2]

Summary of findings 2Summary of findings table 2**ITNs versus no intervention for preventing leishmaniasisPatient or population:** People at risk of CL or VL\
**Settings:** CL or VL endemic areas\
**Intervention:** ITNs\
**Comparison:** No intervention**OutcomesIllustrative comparative risks\* (95% CI)Relative effect (95% CI)No of participants (trials)Quality of the evidence (GRADE)CommentsAssumed riskCorresponding riskNo interventionITNsVector density**‐‐Not pooled(3 trials)⊕⊕⊝⊝ **low**^1,2,3,4^Two trials found a reduction in vector numbers post‐intervention and one did not.**CL cases**\
\> 12 months follow‐up**52 per 100016 per 1000**\
(9 to 28)**RR 0.31**\
(0.18 to 0.53)**10,579**\
(2 trials)⊕⊕⊝⊝ **low**^2,5,6,7,11^‐**VL cases**\
\> 2 years follow‐up**4 per 10004 per 1000**\
(2 to 9)**RR 0.99**\
(0.46 to 2.15)**19,810**\
(1 trial)⊕⊕⊕⊝ **moderate**^8,9,10^‐\*The basis for the **assumed risk** is provided in footnotes. The **corresponding risk** (and its 95% CI) is based on the assumed risk in the comparison group and the **relative effect** of the intervention (and its 95% CI). **CI:** confidence interval; **RR:** risk ratio; **CL:** cutaneous leishmaniasis; **VL:** visceral leishmaniasis; **ITN:** insecticide treated bednet.GRADE Working Group grades of evidence **High quality:** Further research is very unlikely to change our confidence in the estimate of effect. **Moderate quality:** Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. **Low quality:** Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. **Very low quality:** We are very uncertain about the estimate.[^3]

Summary of findings 3Summary of findings table 3**ITCs versus no intervention for preventing leishmaniasisPatient or population:** People at risk of CL or VL\
**Settings:** CL or VL endemic areas\
**Intervention:** ITCs\
**Comparison:** No intervention**OutcomesIllustrative comparative risks\* (95% CI)Relative effect (95% CI)No of participants (trials)Quality of the evidence (GRADE)CommentsAssumed riskCorresponding riskNo interventionInsecticide treated curtainsVector density**‐‐‐‐\
(1 trial)⊕⊕⊝⊝ **low**^1,2,3^Vector density was substantially lower at 12 months post‐intervention**CL cases**\
\> 12 months follow‐up**52 per 10000 per 1000**\
(0 to 25)**RR 0.00**\
(0.00 to 0.49)**2938**\
(1 trial)⊕⊕⊝⊝ **low**^1,2,4,5^‐**VL cases**\
\> 2 years follow‐up‐‐‐(0 trials)‐‐\*The basis for the **assumed risk** is provided in footnotes. The **corresponding risk** (and its 95% CI) is based on the assumed risk in the comparison group and the **relative effect** of the intervention (and its 95% CI). **CI:** confidence interval; **RR:** risk ratio; **CL:** cutaneous leishmaniasis; **VL:** visceral leishmaniasis;**ITC**: insecticide treated curtains.GRADE Working Group grades of evidence **High quality:** Further research is very unlikely to change our confidence in the estimate of effect. **Moderate quality:** Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. **Low quality:** Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. **Very low quality:** We are very uncertain about the estimate.[^4]

Summary of findings 4Summary of findings table 4**ITS versus no intervention for preventing leishmaniasisPatient or population:** People at risk of CL or VL\
**Settings:** CL or VL endemic areas\
**Intervention:** ITS\
**Comparison:** No intervention**OutcomesIllustrative comparative risks\* (95% CI)Relative effect (95% CI)No of participants (trials)Quality of the evidence (GRADE)CommentsAssumed riskCorresponding riskNo interventionITSVector density**‐‐‐(1 trial)⊕⊝⊝⊝ **very low**^1,2,3,4^No data post‐intervention.**CL cases**\
\> 12 months follow‐up**52 per 100018 per 1000** (10 to 30)**RR 0.34** (0.20 to 0.57)2784\
(1 trial)⊕⊕⊝⊝ **low**^2,5,6^‐**VL cases**\
\> 2 years follow‐up‐‐‐(0 trials)‐‐\*The basis for the **assumed risk** is provided in footnotes. The **corresponding risk** (and its 95% CI) is based on the assumed risk in the comparison group and the **relative effect** of the intervention (and its 95% CI). **CI:** confidence interval; **RR:** risk ratio; **CL:** cutaneous leishmaniasis; **VL:** visceral leishmaniasis; **ITS:** insecticide treated bedsheet.GRADE Working Group grades of evidence **High quality:** Further research is very unlikely to change our confidence in the estimate of effect. **Moderate quality:** Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. **Low quality:** Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. **Very low quality:** We are very uncertain about the estimate.[^5]

Summary of findings 5Summary of findings table 5**Insecticide treated uniforms versus no intervention for preventing leishmaniasisPatient or population:** People at risk of CL or VL\
**Settings:** CL or VL endemic areas\
**Intervention:** Insecticide treated uniforms\
**Comparison:** No intervention**OutcomesIllustrative comparative risks\* (95% CI)Relative effect (95% CI)No of participants (trials)Quality of the evidence (GRADE)Assumed riskCorresponding riskNo interventionInsecticide treated uniformsVector density**‐‐‐(0 trials)‐**CL cases**\
\> 12 months follow‐up**52 per 100021 per 1000**\
(7 to 62)**RR 0.40** (0.13 to 1.20)**558**\
(2 trials)⊕⊕⊝⊝ **low**^1,2,3,4,5^**VL cases**\
\> 2 years follow‐up‐‐(0 trials)^‐^\*The basis for the **assumed risk** is provided in footnotes. The **corresponding risk** (and its 95% CI) is based on the assumed risk in the comparison group and the **relative effect** of the intervention (and its 95% CI). **CI:** confidence interval; **RR:** risk ratio; **CL:** cutaneous leishmaniasis; **VL:** visceral leishmaniasis.GRADE Working Group grades of evidence **High quality:** Further research is very unlikely to change our confidence in the estimate of effect. **Moderate quality:** Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. **Low quality:** Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. **Very low quality:** We are very uncertain about the estimate.[^6]

Summary of findings 6Summary of findings table 6**Multifaceted intervention versus no intervention for preventing leishmaniasisPatient or population:** People at risk of CL or VL\
**Settings:** CL or VL endemic areas\
**Intervention:** Multifaceted intervention\
**Comparison:** No intervention**OutcomesIllustrative comparative risks\* (95% CI)Relative effect (95% CI)No of participants (trials)Quality of the evidence (GRADE)Assumed riskCorresponding riskNo interventionMultifaceted interventionVector density**‐‐‐0 trials‐**CL cases**\
12 months follow‐up**13 per 10006 per 1000RR 0.42**\
(0.13 to 1.41)**3631**\
(1 trial)⊕⊝⊝⊝\
**very low**^1,2,3^**VL cases**\
\> 2 years follow‐up‐‐‐0‐\*The basis for the **assumed risk** (for example, the median control group risk across trials) is provided in footnotes. The **corresponding risk** (and its 95% CI) is based on the assumed risk in the comparison group and the **relative effect** of the intervention (and its 95% CI). **CI:** Confidence interval; **RR:** risk ratio; **CL:** cutaneous leishmaniasis; **VL:** visceral leishmaniasis; **ITNs:** insecticide treated bednets.GRADE Working Group grades of evidence **High quality:** Further research is very unlikely to change our confidence in the estimate of effect. **Moderate quality:** Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. **Low quality:** Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. **Very low quality:** We are very uncertain about the estimate.[^7]

Summary of findings 7Summary of findings table 7**IRS versus ITNs for preventing leishmaniasisPatient or population:** People at risk of CL or VL\
**Settings:** CL or VL endemic areas\
**Intervention:** IRS\
**Comparison:** ITNs**OutcomesIllustrative comparative risks\* (95% CI)Relative effect (95% CI)No of participants (trials)Quality of the evidence (GRADE)CommentsAssumed riskCorresponding riskITNsIRSVector density**‐‐Not pooled‐\
(2 trials)⊕⊕⊝⊝ **low**^1,2,3^One trial found a reduction in vector numbers post‐intervention and one trial did not.**CL cases**\
\> 12 months follow‐up**15 per 100030 per 1000RR 1.90**\
(0.98 to 3.69)1655\
(1 trial)⊕⊕⊝⊝ **low**^1,4,5,6^‐**VL cases**\
\> 2 years follow‐up‐‐‐(0 trials)‐‐\*The basis for the **assumed risk** is provided in footnotes. The **corresponding risk** (and its 95% CI) is based on the assumed risk in the comparison group and the **relative effect** of the intervention (and its 95% CI). **CI:** Confidence interval; **RR:** risk ratio; **CL:** cutaneous leishmaniasis; **VL:** visceral leishmaniasis.GRADE Working Group grades of evidence **High quality:** Further research is very unlikely to change our confidence in the estimate of effect. **Moderate quality:** Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. **Low quality:** Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. **Very low quality:** We are very uncertain about the estimate.[^8]

Background {#CD008736-sec1-0002}
==========

Description of the condition {#CD008736-sec2-0001}
----------------------------

Leishmaniasis is a group of diseases caused by infection with *Leishmania* species parasites. Two broad clinical syndromes affect people ([@CD008736-bbs2-0055]):

Cutaneous or tegumental leishmaniasis (CL), where *Leishmania* parasites infect the skin or mucous membranes; andVisceral leishmaniasis (VL), also known as Kala‐Azar, where *Leishmania* parasites infect internal organs, such as the spleen, liver, bone marrow and lymph nodes.

The World Health Organization (WHO) considers leishmaniasis to be one of the most serious parasitic diseases in terms of prevalence and geographical distribution. Approximately 350 million, often impoverished, people are at risk of contracting leishmaniasis ([@CD008736-bbs2-0035]). Worldwide, more than 20 *Leishmania* species are known to infect humans across 98 countries or territories ([@CD008736-bbs2-0036]). The WHO estimates that one million to 1.3 million new cases occur each year; one million for CL and 300,000 for VL ([@CD008736-bbs2-0062]).

In the Old World (North Africa, the Mediterranean, the Middle East, Northeast of India, and Central Asia), CL is most commonly caused by *Leishmania major*, *Leishmania tropica* and *Leishmania aethiopica*, and less frequently by *Leishmania infantum* and *Leishmania donovani* ([@CD008736-bbs2-0036]). In the New World (Central and South America), CL may be caused by the *Leishmania mexicana* species complex (particularly *L. mexicana*, *Leishmania amazonensis* and *Leishmania venezuelensis*) or the *Leishmania Viannia* sub‐genus (particularly *Leishmania (V) braziliensis*, *Leishmania (V) panamensis*,*Leishmania (V) guyanensis* and *Leishmania (V) peruviana*). Half of the skin lesions caused by *L. mexicana* heal in three months, while those due to *L. (V) braziliensis*,*L. (V) panamensis* and *L. (V) guyanensis* persist for much longer and may evolve to mucocutaneous leishmaniasis. VL is caused by *L. donovani* in the Indian subcontinent and East Africa, and *L. infantum* in the Middle East, the Mediterranean basin and South America ([@CD008736-bbs2-0063]).

Several drug (topical and systemic), physical and immunological therapeutic modalities have been used for leishmaniasis treatment ([@CD008736-bbs2-0039]; [@CD008736-bbs2-0046]; [@CD008736-bbs2-0047]; [@CD008736-bbs2-0058]).

The infection is transmitted between humans (anthroponotic leishmaniasis) or from animals to humans (zoonotic leishmaniasis) by the bite of infected phlebotomine sandflies ([@CD008736-bbs2-0041]). Sandflies can breed in cracks, in walls or among rocks, animals\' burrows, caves, damp leaf litter in forests, holes in the ground, stable floors, poultry houses and termite hills. Both male and female phlebotomine sandflies feed on sugar and plants juices but the females also blood‐feed. Female phlebotomine sandflies usually bite at night; some species feed indoors (endophagic), whilst others feed outdoors (exophagic) ([@CD008736-bbs2-0057]). In the Old World, the sandfly vectors belong to the genus *Phlebotomus,* while in the New World they belong to the genus *Lutzomyia.* Due to a co‐evolution process, there is an association between the *Leishmania* species, its animal reservoir (host) and the phlebotomine sandfly species involved in the transmission of leishmaniasis ([Table 19](#CD008736-tbl-0019){ref-type="table"}).Table 1Association between the *Leishmania* species, its animal reservoir and the sandfly species involved in the leishmaniasis transmission** CLEpidemiological form*Leishmania* speciesSandfly speciesReservoirClinical formOther clinical forms Old World**Anthroponotic *L. tropicaP. sergenti*HumanUrban endemic CL Mucocutaneous, recidivans (chronic)Zoonotic *L. majorP. papatasi*,*P. duboscqi*RodentsRural epidemic CL Mucocutaneous*L. aethiopicaP. longipes*, *P. pedifer*HyraxesCLDiffuse*L. infantumP. perniciosus*, *P. ariasi*, *P. perfiliewi*, *P. longiductus*, *P. chinensis*DogsMucocutaneous** New World**Zoonotic*L. mexicana*    *Lu. olmeca*RodentsCLDisseminated*L. amazonensisLu. flaviscutellata*Canids, monkeys, rodents, marsupialsDiffuse, disseminated*L. braziliensisLu. intermedia*, *Lu. gomezi*,*Lu. wellcomei*, *Lu. whitmani*,  *Lu. carrerai*, *Lu. yucumensis*, *Lu. llanosmartinsi*, *Lu. spinicrassa*,*Lu. ovallesi*Edentates, opossums, rodents and dogsMucocutaneous, disseminated*L. panamensisLu. rapidoi*, *Lu. gomezi*, *Lu. ylephiletor*, *Lu. panamensis*Sloths, marsupials, rodents*L. guyanensisLu. umbratilis*, *Lu. whitmani*, *Lu. anduzei*, *Lu. longiflocosa*Sloths, edentates, marsupialsMucocutaneous, disseminatedAnthroponotic*L. peruvianaLu. ayacuchensis*, *Lu. peruensis, Lu. verrucarum*Humans, dogs?Mucocutaneous (rare)** VLEpidemiological form*Leishmania* speciesSandfly speciesReservoirClinical formPossible outcome Old World**Anthroponotic*L. donovaniP. argentipes*, *P. orientalis*, *P. martini*HumanVLPKDLZoonotic*L. infantumP. perniciosus*, *P. ariasi*, *P. perfiliewi*, *P. neglectus*, *P. longiductus*, *P. chinensis* and othersDogsCL** New World**Zoonotic*L. infantum*\
(= *L. chagasi*)*Lu. longipalpis*,*Lu. evansi*Dogs, marsupialsVLPKDL (extremely rare)[^9]

Description of the intervention {#CD008736-sec2-0002}
-------------------------------

Leishmaniasis could be prevented by reducing the number of infected phlebotomine sandflies (vector control), or by reducing the animal reservoir of *Leishmania* in areas where the disease in commonly zoonotic (reservoir control). One further possibility is the development of effective human vaccines, but these are evaluated in a separate Cochrane Review ([@CD008736-bbs2-0052]).

In general, phlebotomine sandflies are highly sensitive to insecticides although some resistance to DDT has been reported ([@CD008736-bbs2-0043]). Insecticide may be sprayed onto the internal walls of houses, also known as indoor residual spraying (IRS), or impregnated into bednets (also known as insecticide treated nets (ITNs)), curtains (insecticide treated curtains (ITCs)), bedsheets (insecticide treated sheets (ITS)) or clothing. IRS is the most widely used intervention for controlling endophagic phlebotomine sandflies but needs to be repeated regularly, which decreases its long‐term sustainability ([@CD008736-bbs2-0040]). ITNs and ITCs also need to be replaced or retreated regularly but usually less frequently than IRS, and therefore may be more sustainable. However, most phlebotomine sandfly activity occurs around sunset, generally before people have retired for the night, which may limit their effects ([@CD008736-bbs2-0057]). In areas where phlebotomine sandflies are typically exophagic or leishmaniasis represents an occupational hazard, such as for soldiers or hunters, the use of insect repellents or protective clothes may be the only preventive measures available ([@CD008736-bbs2-0034]), but it is unlikely to be practical or affordable for poor populations living in highly endemic areas.

Alternatively, phlebotomine sandfly numbers could be reduced by removing breeding sites from the environment through activities such as re‐plastering of cracks in walls with mud or lime ([@CD008736-bbs2-0053]).

The methods used to control the reservoir (host) of zoonotic leishmaniasis depend on which animals act as reservoirs. Dogs play an important role as leishmaniasis reservoirs in some areas, and development of appropriate control measures is necessary ([@CD008736-bbs2-0038]; [@CD008736-bbs2-0044]; [@CD008736-bbs2-0054]). Other animal reservoirs, such as rodents, have been targeted through poisonous baits ([@CD008736-bbs2-0057]).

Since disease control efforts are focused on reducing sandfly‐human contact or sandfly populations, other leishmaniasis control strategies on socioeconomic aspects should include ([@CD008736-bbs2-0035]):

Fight against poverty.Gender equality and elimination of other sociocultural barriers.Access to health care (mainly in the case of human reservoirs like anthroponotic VL or post kala‐azar dermal leishmaniasis (PKDL), and asymptomatic infections, including direct non‐medical cost as transport).House construction and placement of domestic animal enclosures (poor housing conditions are associated with ecological factors that increase the risk of human‐vector contact).Educational health programmes and community participation.

Why it is important to do this review {#CD008736-sec2-0003}
-------------------------------------

A wide range of leishmaniasis preventive options have been used in different parts of the world. This Cochrane Review aims to summarise available research categorised by disease forms, settings and geographical regions.

Objectives {#CD008736-sec1-0003}
==========

To assess the effects of vector and reservoir control interventions on all forms of leishmaniasis.

Methods {#CD008736-sec1-0004}
=======

Criteria for considering studies for this review {#CD008736-sec2-0004}
------------------------------------------------

### Types of studies {#CD008736-sec3-0001}

Randomized controlled trials (RCTs).

### Types of participants {#CD008736-sec3-0002}

People living in leishmaniasis endemic regions.

### Types of interventions {#CD008736-sec3-0003}

Any intervention that aims to reduce leishmaniasis incidence through vector or reservoir control.

### Types of outcome measures {#CD008736-sec3-0004}

#### Primary outcomes {#CD008736-sec4-0001}

People developing CL or VL infections.

#### Secondary outcomes {#CD008736-sec4-0002}

Estimates of the vector density measured by an appropriate technique (adult sandfly density estimated by counts of vectors either landing on exposed body parts of humans acting as baits or collected resting inside buildings, for example, on walls).Number of participants with positive immunological or biochemical tests that detect contact with the parasite (for example, leishmanin skin test conversion rates or lymphocyte proliferation rates, or both).Adverse effects on people.Adherence to control measures; for example, the extent to which specified intervention components were delivered as prescribed.Measures of environmental impact (assessment of the possible impact ‐ positive or negative ‐ that the interventions may have on the natural environment) or sustainability (assessment of the ability to change biological and human processes, functions, biodiversity and productivity), or both.

Search methods for identification of studies {#CD008736-sec2-0005}
--------------------------------------------

We attempted to identify all relevant trials regardless of language or publication status (published, unpublished, in press and ongoing).

### Electronic searches {#CD008736-sec3-0005}

We searched the following databases up to 13 January 2015: Cochrane Infectious Diseases Group (CIDG) Specialized Register, [Appendix 1](#CD008736-sec2-0015){ref-type="app"}); the Cochrane Central Register of Controlled Trials (CENTRAL) from the Cochrane Library, Issue 12, 2014 ([Appendix 2](#CD008736-sec2-0016){ref-type="app"}); MEDLINE (PubMed.gov from 1900, [Appendix 3](#CD008736-sec2-0017){ref-type="app"}); EMBASE (Data Star, from 1947, [Appendix 4](#CD008736-sec2-0018){ref-type="app"}); LILACS, from 1982 ([Appendix 5](#CD008736-sec2-0019){ref-type="app"}), WHOLIS ([Appendix 6](#CD008736-sec2-0020){ref-type="app"}), Web of Science (Science Direct, from 1900, [Appendix 7](#CD008736-sec2-0021){ref-type="app"}); and RePORT Expenditures and Results (RePORTER) which contains information on controlled trials being funded or supported by the US Department of Health and Human Services http://projectreporter.nih.gov/reporter.cfm, [Appendix 8](#CD008736-sec2-0022){ref-type="app"}).

#### Ongoing trials databases {#CD008736-sec4-0003}

We searched the following ongoing trials registers on 13 January 2015 using the strategies in [Appendix 9](#CD008736-sec2-0023){ref-type="app"}:

MetaRegister of Controlled trials on www.controlled‐trials.com;US National Institutes of Health Register on www.clinicaltrials.gov;Ongoing Skin Trials Register on www.nottingham.ac.uk/ongoingskintrials;Australian and New Zealand Clinical Trials Registry on www.anzctr.org.au;World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) on www.who.int/trialsearch.

### Searching other resources {#CD008736-sec3-0006}

#### References from published studies {#CD008736-sec4-0004}

We looked at the bibliographies of all papers identified by these strategies.

#### Researchers, organizations and pharmaceutical companies {#CD008736-sec4-0005}

We contacted researchers in the field to identify additional studies eligible for inclusion.

#### Adverse events search {#CD008736-sec4-0006}

We searched for adverse or side effects of interventions using the search strategy in [Appendix 10](#CD008736-sec2-0024){ref-type="app"}.

Data collection and analysis {#CD008736-sec2-0006}
----------------------------

### Selection of studies {#CD008736-sec3-0007}

At least two review authors (AF, MP or UG) independently screened the title and abstract of all identified citations for potential eligibility using an eligibility form. We resolved any disagreements by discussion between the review authors, with referral to a third review author if necessary (UG or JA). We removed duplicate publications.

### Data extraction and management {#CD008736-sec3-0008}

At least two review authors (CE and AF; CE and MP; or all three) independently performed data extraction using a pre‐designed data extraction form. We resolved any disagreements by discussion or referral to another review author (UG).

We extracted information regarding the trial characteristics and trial methods, including setting, comparability between sites and outcomes and how these were measured. For dichotomous outcomes, we extracted the number of participants experiencing the event and the number of participants for each treatment group. For continuous outcomes, we extracted the arithmetic mean and standard deviation (SD) for each treatment group, together with the number of participants in each group. However, if the data were reported using geometric means we recorded this information and extracted a SD on the log scale. If median values were used, we extracted medians and ranges. For data on an interval scale, we extracted the number of treatment events and control group and the total person time at risk in each group or the rate ratio and a measure of variance (for example, standard error).

We extracted the number of randomized participants and analysed them in each treatment group and the denominator populations for estimating incidence for each trial and outcome. We checked for co‐interventions and we examined whether both control and intervention arms experienced the same co‐interventions.

For cluster‐RCTs, we extracted information on the number of clusters, average size of the cluster, unit of randomization (such as communities or villages), adjustment for clustering or other covariates in the statistical analysis, and estimates of the intra‐cluster correlation coefficient (ICC) for each outcome. Where results were adjusted for clustering, we extracted the point estimate with 95% confidence intervals (CIs); otherwise we adjusted the unadjusted results before incorporating them into our analyses.

### Assessment of risk of bias in included studies {#CD008736-sec3-0009}

Pairs of review authors (including AF, MP or CE) (AF, MP and CE) independently assessed the risk of bias for each included trial using a \'Risk of bias\' assessment form. We resolved any discrepancies between the results of the risk of bias analysis by referral to a third review author (UG). We assigned judgments concerning the risk of bias for each component classified as \'high\', \'low\' or \'unclear\' risk of bias, respectively. We recorded the information in a \'Risk of bias\' table and \'Risk of bias\' graph.

### Measures of treatment effect {#CD008736-sec3-0010}

For dichotomous outcomes, we presented all results as risk ratios (RR) with 95% CIs. Where trial authors presented results as cluster‐adjusted odds ratio we converted this to a RR using the guidance in the *Cochrane Handbook for Systematic Reviews of Interventions* ([@CD008736-bbs2-0050]). We presented vector density and other outcomes, such as ages of cases, descriptively in tables.

### Unit of analysis issues {#CD008736-sec3-0011}

Where cluster‐RCTs met the inclusion criteria, we assessed whether the trial authors had taken account of clustering in the primary analysis. If trial authors had appropriately adjusted for clustering we extracted the adjusted data for inclusion in our analysis. Where trial authors had not adjusted for clustering, we performed an approximate adjustment using estimates of the ICC derived from similar studies ([Table 20](#CD008736-tbl-0020){ref-type="table"}).Table 2Analysis of cluster‐RCTs reporting clinical outcomes**Trial IDUnitMean cluster populationNumber of clustersCluster adjustment by trial authorsApproximate ICC calculated by review authors^1^Cluster adjustment by review authors^2^**[@CD008736-bbs2-0003]Geographical area1134\"We specify a model that explicitly considered the effect of aggregation of the individual in clusters (cluster effect) and used methods of robust estimation of variance. Data analysis was performed using STATA software.\"Unable to calculate because the raw data were not presented.None necessary.[@CD008736-bbs2-0005]Urban sectors63512None (analysed at the individual level).‐SE adjusted for clustering using the ICC from [@CD008736-bbs2-0012].[@CD008736-bbs2-0009]City sectors21014\'We compared data using a paired t test, weighting the data according to the sector size. We also used Wilcoxon\'s matched pairs test because the small number of pairs made it difficult to assess whether the underlying distribution of the differences was normal\'.Unable to calculate as authors only presented mean difference adjusted for clustering.RR was calculated from raw data and the SE adjusted for clustering using the ICC from [@CD008736-bbs2-0012].[@CD008736-bbs2-0010]Hamlets76126\"Adjusted analyses were carried out in two stages\...a standard individual level logistic regression model to calculate expected number of events for each cluster ignoring the intervention\...The adjusted intervention effect was calculated with these residuals in a paired t test\".0.0010None necessary.[@CD008736-bbs2-0011]Household5957\"Because the interventions were allocated at household level, the data were analysed by a random effects logistic regression model to adjust for the possibility that individuals within a household might be more similar with respect to the intervention outcome than individuals from other households\".0.0321Converted from OR to RR using the formula:\
RR = OR/(1‐ACRx(1‐OR)).[@CD008736-bbs2-0012]Village18220\"Once the final model was defined, the generalized estimating equations method was used to estimate the parameters while taking into account the correlation of observations within villages\".0.0034None necessary.[@CD008736-bbs2-0014]City blocks containing ≈ 60 households7040\"using Poisson population‐average models from generalized estimating equations with robust variance, an exchangeable correlation model, and designating each block as the clustering level\".‐None necessary.[^10]

### Dealing with missing data {#CD008736-sec3-0012}

We reported whether participants or communities were lost to follow‐up during the time period of the trial. We analysed data according to a complete case analysis. We performed sensitivity analyses to asses the effect of missing data and to ensure the robustness of our conclusions.

### Assessment of heterogeneity {#CD008736-sec3-0013}

When we combined trials in a meta‐analysis, we examined forest plots to detect overlapping CIs, and applied the Chi² test (using a P value of 0.10 to indicate statistical heterogeneity), and the I² statistic (using a value of 50% to denote moderate levels of heterogeneity).

### Assessment of reporting biases {#CD008736-sec3-0014}

We searched for citation and multiple publication bias, language bias and outcome reporting bias.

### Data synthesis {#CD008736-sec3-0015}

Three review authors (DS, TE and UG) analysed the data using [@CD008736-bbs2-0056] and presented all results with 95% CIs.

In individually RCTs and cluster‐RCTs, we calculated RRs and 95% CIs for dichotomous data. We did not analyse vector densities, but merely presented the results of the individual trials. We could not consider meta‐analysis to calculate a weighted effect across trials regarding participants (different *Leishmania* spp infections), interventions (reservoir and vector control) and outcome. We aimed to perform an intention‐to‐treat (ITT) analysis when the trial authors accounted for all randomized participants; otherwise we performed a complete‐case analysis.

When we detected no statistically significant heterogeneity, we applied a fixed‐effect model. When we observed statistically significant heterogeneity within groups that could not be explained by subgroup or sensitivity analyses, we applied a random‐effects model to synthesize the data. However, when substantial heterogeneity was determined, we did not carry out meta‐analysis but presented a forest plot with the pooled effect suppressed and reported the I² statistic and P value from a Chi² test.

We described qualitatively the main adverse effects related with insecticides.

### Subgroup analysis and investigation of heterogeneity {#CD008736-sec3-0016}

We anticipated that effects would vary with leishmania species, and the geographic setting of the trial, and grouped studies accordingly.

### Sensitivity analysis {#CD008736-sec3-0017}

We planned to conduct sensitivity analysis examining effects of bias risk but there were too few included trials to do this.

#### Assessment of quality of evidence {#CD008736-sec4-0007}

We assessed the quality of evidence using the GRADE approach ([@CD008736-bbs2-0048]) and [@CD008736-bbs2-0049] software.

Results {#CD008736-sec1-0005}
=======

Description of studies {#CD008736-sec2-0007}
----------------------

See: [Characteristics of included studies](#CD008736-sec2-0027){ref-type="sec"} and [Characteristics of excluded studies](#CD008736-sec2-0028){ref-type="sec"}.

### Results of the search {#CD008736-sec3-0018}

We identified 32 trials from our searches, of which we included 14 and excluded 18. We found one ongoing RCT ([Characteristics of ongoing studies](#CD008736-sec2-0029){ref-type="sec"}). We have detailed our search results in a PRISMA flow diagram ([Figure 1](#CD008736-fig-0001){ref-type="fig"}).Figure 1Study flow diagram.

### Included studies {#CD008736-sec3-0019}

We have provided details of the 14 included trials in the [Characteristics of included studies](#CD008736-sec2-0027){ref-type="sec"} tables.

#### Trial design {#CD008736-sec4-0008}

Ten trials were cluster‐RCTs that randomized villages ([@CD008736-bbs2-0012]), urban sectors ([@CD008736-bbs2-0003]; [@CD008736-bbs2-0005]; [@CD008736-bbs2-0009]; [@CD008736-bbs2-0014]), hamlets or households ([@CD008736-bbs2-0002]; [@CD008736-bbs2-0007]; [@CD008736-bbs2-0010]; [@CD008736-bbs2-0011]) or individual houses ([@CD008736-bbs2-0008]). Two were paired RCTs that randomized houses ([@CD008736-bbs2-0004]; [@CD008736-bbs2-0006]). Two were individually RCTs in soldiers ([@CD008736-bbs2-0001]; [@CD008736-bbs2-0013]).

#### Participants {#CD008736-sec4-0009}

Seven trials were conducted in Asia: Afghanistan ([@CD008736-bbs2-0011]), Iran ([@CD008736-bbs2-0001]; [@CD008736-bbs2-0005]), India ([@CD008736-bbs2-0004]), Bangladesh ([@CD008736-bbs2-0002]), India and Nepal ([@CD008736-bbs2-0010]), India, Bangladesh and Nepal ([@CD008736-bbs2-0007]). Seven trials were conducted in South America: Colombia ([@CD008736-bbs2-0012]; [@CD008736-bbs2-0013]), Brazil ([@CD008736-bbs2-0003]; [@CD008736-bbs2-0008]; [@CD008736-bbs2-0014]) and Venezuela ([@CD008736-bbs2-0006]; [@CD008736-bbs2-0009]).

#### Settings {#CD008736-sec4-0010}

Most trials mentioned the which *Leishmania* species were endemic in the area and therefore assumed this species was the causative agent of leishmaniasis. One RCT reported that CL was caused by *L. tropica* ([@CD008736-bbs2-0005]), three RCTS by *L. chagasi* (*L. infantum*) ([@CD008736-bbs2-0003]; [@CD008736-bbs2-0008]; [@CD008736-bbs2-0014]), one trial by *L. braziliensis* and *L. panamensis* ([@CD008736-bbs2-0012]), and one trial by *L. braziliensis* and *L. mexicana* ([@CD008736-bbs2-0006])*.* Three RCTs reported that VL was caused by *L. donovani* ([@CD008736-bbs2-0002]; [@CD008736-bbs2-0004]; [@CD008736-bbs2-0010]). Four RCTs failed to mention the*Leishmania* species involved: one in a VL area ([@CD008736-bbs2-0007]) and three in CL areas ([@CD008736-bbs2-0001]; [@CD008736-bbs2-0009]; [@CD008736-bbs2-0013]). One RCT reported that infections in the respective endemic areas were caused by anthroponotic CL ([@CD008736-bbs2-0011]).

#### Interventions {#CD008736-sec4-0011}

We found 12 RCTs that evaluated the use of insecticides in vector control. Trials used a variety of different interventions, including IRS (five trials: [@CD008736-bbs2-0002]; [@CD008736-bbs2-0006]; [@CD008736-bbs2-0007]; [@CD008736-bbs2-0008]; [@CD008736-bbs2-0011]), ITNs (six trials: [@CD008736-bbs2-0002]; [@CD008736-bbs2-0005]; [@CD008736-bbs2-0007]; [@CD008736-bbs2-0010]; [@CD008736-bbs2-0011]; [@CD008736-bbs2-0012]), ITCs (one trial: [@CD008736-bbs2-0009]), ITS (two trials: [@CD008736-bbs2-0008]; [@CD008736-bbs2-0011]) or insecticide treated uniforms (two trials: [@CD008736-bbs2-0001]; [@CD008736-bbs2-0013]).

Two additional trials evaluated IRS plus reservoir control through spraying houses and animal pens and eliminating infected dogs ([@CD008736-bbs2-0003]; [@CD008736-bbs2-0014]).

#### Outcomes {#CD008736-sec4-0012}

Seven trials reported clinical outcomes as the incidence of new CL cases ([@CD008736-bbs2-0001]; [@CD008736-bbs2-0005]; [@CD008736-bbs2-0009]; [@CD008736-bbs2-0011]; [@CD008736-bbs2-0012]; [@CD008736-bbs2-0013]), or VL ([@CD008736-bbs2-0010]). Four trials used immunological or biochemical tests ([@CD008736-bbs2-0003]; [@CD008736-bbs2-0010]; [@CD008736-bbs2-0012]; [@CD008736-bbs2-0014]) for detecting the presence of the *Leishmania* parasite on participants (for example, leishmanin skin test conversion rates or lymphocyte proliferation rates, or both). Six trials ([@CD008736-bbs2-0003]; [@CD008736-bbs2-0004]; [@CD008736-bbs2-0005]; [@CD008736-bbs2-0007]; [@CD008736-bbs2-0008]; [@CD008736-bbs2-0009]) reported on entomological outcomes (vector density). Only three trials reported adverse effects ([@CD008736-bbs2-0001]; [@CD008736-bbs2-0012]; [@CD008736-bbs2-0013]). Two trials reported acceptability and adherence to control measures from participants (for example, the extent to which specified intervention components were delivered as prescribed) ([@CD008736-bbs2-0010]; [@CD008736-bbs2-0011]).

### Excluded studies {#CD008736-sec3-0020}

We excluded 18 RCTs and listed the reasons in the [Characteristics of excluded studies](#CD008736-sec2-0028){ref-type="sec"} table.

Risk of bias in included studies {#CD008736-sec2-0008}
--------------------------------

We have described the risk of bias of each included trial in the [Characteristics of included studies](#CD008736-sec2-0027){ref-type="sec"} tables. We included a \'Risk of bias\' summary ([Figure 2](#CD008736-fig-0002){ref-type="fig"}) and a \'Risk of bias\' graph ([Figure 3](#CD008736-fig-0003){ref-type="fig"}).Figure 2Methodological quality graph: review authors\' judgements about each methodological quality item presented as percentages across all included trials.Figure 3Methodological quality summary: review authors\' judgements about each methodological quality item for each included trial.

### Allocation {#CD008736-sec3-0021}

AIl included trials stated or implied that allocation was randomized; however only five trials described the method of sequence generation ([@CD008736-bbs2-0005]; [@CD008736-bbs2-0009]; [@CD008736-bbs2-0010]; [@CD008736-bbs2-0012]; [@CD008736-bbs2-0014]), and no trials described allocation concealment.

### Blinding {#CD008736-sec3-0022}

Two included RCTs were double‐blinded ([@CD008736-bbs2-0001]; [@CD008736-bbs2-0013]), two were single‐blinded ([@CD008736-bbs2-0009]; [@CD008736-bbs2-0011]), and ten trials did not use any blinding or did not mention it.

### Incomplete outcome data {#CD008736-sec3-0023}

An individually RCT accounted for losses to follow‐up ([@CD008736-bbs2-0001]), and the other individually RCT reported no drop‐outs ([@CD008736-bbs2-0013]). However, [@CD008736-bbs2-0001] only assessed participants who completed the use of the preventive measure. We took all participants that were randomized at the beginning of the trial to evaluate the final effect of the intervention. We assumed that missing data were failures. The trial did not specify if they were post randomization or later losses. Overall there was no losses of clusters or the losses were not reported.

### Selective reporting {#CD008736-sec3-0024}

One of the included trials, [@CD008736-bbs2-0004], reported only the results that showed statistically significant differences between intervention groups, instead of all results.

### Other potential sources of bias {#CD008736-sec3-0025}

In nine of the included RCTs the trial authors did not provide a conflict of interest declaration and in five of the included RCTs trial authors declared no competing interests. See risk of bias tables in [Characteristics of included studies](#CD008736-sec2-0027){ref-type="sec"} for more details.

Effects of interventions {#CD008736-sec2-0009}
------------------------

See: [Table 1](#CD008736-tbl-0001){ref-type="table"}; [Table 2](#CD008736-tbl-0002){ref-type="table"}; [Table 3](#CD008736-tbl-0003){ref-type="table"}; [Table 4](#CD008736-tbl-0004){ref-type="table"}; [Table 5](#CD008736-tbl-0005){ref-type="table"}; [Table 6](#CD008736-tbl-0006){ref-type="table"}; [Table 7](#CD008736-tbl-0007){ref-type="table"}

### Section A: Intervention versus no intervention {#CD008736-sec3-0026}

#### IRS versus no intervention {#CD008736-sec4-0013}

(See [Table 1](#CD008736-tbl-0001){ref-type="table"})

##### Effect on vector density {#CD008736-sec5-0001}

Four cluster‐RCTs evaluated the effect of IRS on vector density ([Table 21](#CD008736-tbl-0021){ref-type="table"}). The insecticide used was deltamethrin (20 mg/m²) in Bangladesh ([@CD008736-bbs2-0002]), DDT (5%) in India, and alpha‐cypermethrine (0.025 mg/m²) in Nepal ([@CD008736-bbs2-0007]), all against the vector *Phlebotomous argentipes;* and lambdacyhalothrin (25 mg/m²) in Brazil ([@CD008736-bbs2-0008]) and Venezuela ([@CD008736-bbs2-0006]), with main vectors: *Lu. longipalpis* and *Lu. ovallesi*, respectively. The longest follow‐up was 12 months.Table 3Vector density: IRS versus no intervention**Trial IDUnit of randomizationInsecticideMain vectorMeasure (method)Pre‐interventionPost‐interventionEffect measure (95% CI) or P valueIRSControlIRSControl**[@CD008736-bbs2-0002]Cluster of 50 housesDeltamethrin (20 mg/m²)*P. argentipes*Total sandflies\
(monthly collections from 40 houses using light traps).633 (October 2006)683 (October 2006)8 (January 2007)\
285 (March 2007)54 (January 2007)\
1219 (March 2007)RR 0.38 (0.10 to 1.50) (Jan 2007)\
RR 0.28 (0.19 to 0.42) (Mar 2007)\
The benefit with IRS was no longer present at 12 months[@CD008736-bbs2-0007]Hamlets or neighbourhoodsDeltamethrin ‐ BGD (20 mg/m²)\
DDT ‐ IND (1 g/m²)\
Alpha‐cypermethrin ‐ NPL (0.025 g/m²)*P. argentipes*Mean number of sandflies per house per night (light traps)12.32\
(date not stated)9.41\
(Date not stated)6.14\
(5 months post intervention)12.15\
(5 months post intervention)Pre‐intervention P = 0.184\
Post‐intervention P = 0.035[@CD008736-bbs2-0008]Chicken shedsLambdacyhalothrin\
(20 mg/m²)*Lu.longipalpis*Geometric mean sandflies (light traps)1132.3\*\
(October 1993)404.6\*\
(October 1993)Not reportedNot reportedPre‐intervention P \< 0.001\
The trial authors state \"the abundance of *Lu. longipalpis* in sprayed sheds fell to approximately 10% of that expected, and remained so up to week 29\".[@CD008736-bbs2-0006]HouseLambdacyhalothrin (25 mg/m²)*Lu. ovallesi*Total sandflies over 79 days post‐intervention\
(daily catches using light traps)Not reportedNot reported25172472The trial authors state \"The estimated catches of males, females, and fed females were significantly lower in sprayed houses immediately after spraying\". However, over time the density in the control group also decreased ‐ probably due to seasonalityProportion of blood fed femalesNot reportedNot reported0.8%5.8%[^11]

All four trials reported substantial reductions in vectors at the intervention sites, although the variation in measurement and reporting of these outcomes precludes meta‐analysis. Despite marked seasonal variation in the abundance of flies, large reductions were seen with IRS compared to control areas in the two trials from Asia in areas of VL which randomized clusters of houses ([@CD008736-bbs2-0002]; [@CD008736-bbs2-0007]). This effect lasted for nine months in Bangladesh but was no longer present at 12 months, and was only measured at a single time‐point of five months in India, Bangladesh and Nepal. The two trials from South America in areas of CL which randomized individual houses or chicken sheds reported short term reductions after the intervention but did not provide data to allow us to quantify the magnitude or duration of this effect ([@CD008736-bbs2-0006]; [@CD008736-bbs2-0008]).

##### Effect on disease {#CD008736-sec5-0002}

**CL:** One cluster‐RCT from Afghanistan evaluated the effect of IRS on CL incidence ([@CD008736-bbs2-0011]). IRS was applied once using lambdacyhalothrin (30 mg/m²). The cumulative analysis of new cases over 15 months showed a marked reduction in clinical cases with IRS (Intervention 36/1133 (3.2%); control 92/1759 (5.2 %); RR 0.61, 95% CI 0.38 to 0.97, one trial, 2892 participants in approximately 600 clusters, [Analysis 1.1](#CD008736-fig-00101){ref-type="fig"}). The effect appears to be consistent across age groups ([Table 22](#CD008736-tbl-0022){ref-type="table"}).Table 4Incidence of new CL cases by intervention and age group in a cluster‐RCT from Afghanistan**Age group (years)IRSITNsInsecticide treated chaddarControl (no intervention)New cases (%)New cases (%)New cases (%)New cases (%)0 to 4**3 (1.9%)1 (0.6%)1 (0.8%)8 (3.7%)**5 to 9**11 (7.9%)3 (2%)4 (3.5%)12 (5.2%)**10 to 19**8 (4.5%)5 (2.5%)4 (2.1%)31 (9.1%)**≥ 20**14 (4.2%)11 (3.3%)9 (3.0%)41 (8.4%)**Total**36 (4.4%)20 (2.4%)18 (2.5%)92 (7.2%)[^12]

**VL:** No trials evaluated the effects of IRS on VL incidence. However, one trial assessed the effect on seroconversion in a VL endemic area in Brazil ([@CD008736-bbs2-0014]) and found no statistically significant difference in seroconversion over 18 months post intervention (Intervention 47/93 (50.5%); control 60/95 (63.2%); RR 0.86, 95% CI 0.63 to 1.17, one trial, 295 participants in 40 clusters, [Analysis 1.2](#CD008736-fig-00102){ref-type="fig"}).

#### ITNs versus no intervention or untreated nets {#CD008736-sec4-0014}

(See [Table 2](#CD008736-tbl-0002){ref-type="table"})

##### Effect on vector density {#CD008736-sec5-0003}

Three cluster‐RCTs evaluated the effect of ITNs on vector density ([Table 23](#CD008736-tbl-0023){ref-type="table"}). Two trials in areas of VL from Asia used PermaNet® bednets impregnated with deltamethrin (55 mg/m²) ([@CD008736-bbs2-0002]; [@CD008736-bbs2-0007], vector: *P. argentipes*); and one trial in Iran used Olyset® bednets impregnated with permethrin (2%) ([@CD008736-bbs2-0005]), main vector: *P. sergenti*). All three trials randomized clusters of houses (hamlets, neighbourhoods or city sectors).Table 5Vector density: ITNs versus no intervention**Trial IDUnit of randomizationInterventionMain vectorMeasure (method)Pre‐interventionPost‐interventionEffect measure (95% CI) or P valueITNsControlITNsControl**[@CD008736-bbs2-0002]Cluster of 50 housesPermaNet® 2.0 (deltamethrin 55mg/m²) distributed to all households in November 2006.*P. argentipes*Total sandflies\
(monthly collections from 40 houses using light traps).724 (October 2006)683 (October 2006)18 (January 2007)\
361 (March 2007)54 (January 2007)\
1219 (March 2007)RR 0.73 (0.23 to 2.25) (Jan 2007)\
RR 0.31 (0.21 to 0.46) (Mar 2007)\
The benefit with ITNs was still present at 12 months[@CD008736-bbs2-0005]City sector (approx. 3000 houses)Olyset® (permethrin 2%) distributed to all households in August 2004.*P. sergenti*Total sandflies\
(monthly collections during transmission season using light traps and sticky traps).Not reportedNot reportedNot reportedNot reportedThe authors state: \'There were statistically significant differences in the monthly catches of *P. sergenti* between control and intervention sectors in both cities (P \< 0.05)\'.[@CD008736-bbs2-0007]Hamlets or neighnourhoodsPermaNet® (deltamethrin 55mg/m²) distributed to all households (date not stated).*P. argentipes*Mean number of sandflies per per house (light traps) per night at all sites pooled in Nepal, Bangladesh and India.9.92\
(date not stated)9.41\
(date not stated)8.32\
(5 months post intervention)12.15\
(5 months post intervention)Pre‐intervention P = 0.798\
Post‐intervention P = 0.16 (The trial authors state the effect was significant in India and Bangladesh but not Nepal)[^13]

In Bangladesh, there was a substantial reduction in vector density in the ITN areas for 12 months post intervention ([@CD008736-bbs2-0002]). In the multicentre trial from Asia, [@CD008736-bbs2-0007], the overall difference between intervention and control sites was not statistically significant. However the trial authors reported that it was significant at the India and Bangladesh sites but not in Nepal. In Iran, the trial authors reported a statistically significant reduction but did not provide data to enable quantification of the magnitude or duration of effect ([@CD008736-bbs2-0005]). Variation in measurement and reporting of these outcomes precluded meta‐analysis.

One additional cluster‐RCT in India that randomized clusters of houses compared two different types of ITNs (PermaNet® bednets impregnated with 55 mg/m² deltamethrin and Olyset® bednets impregnated with 2% permethrin) with two control groups of untreated nets ([Table 24](#CD008736-tbl-0024){ref-type="table"}). The trial authors reported a statistically significant reduction in male *P. argentipes* in areas with ITNs compared to untreated nets, but no difference in female *P. argentipes* or other vectors ([@CD008736-bbs2-0004]).Table 6Vector density: ITNs versus untreated nets**Trial IDUnit of randomizationInterventionMain vectorMeasure (method)Pre‐interventionPost‐interventionEffect measure (95% CI) or P value**[@CD008736-bbs2-0004]Two housesOlyset**®** polyethylene net, impregnated with permethrin (2%).PermaNet® 2.0 impregnated with deltamethrin (55mg/m²).Control: Untreated locally made net.*P. argentipes* and*Sergentomyia* *spp.*Geometric mean sandfly counts per group\
(CDC light traps)Reported graphicallyReported graphicallyThe trial authors state a statistically significant reduction in male *P. argentipides* in areas with ITNs compared to untreated nets, but no difference in female *P. argentipides* or other vectors.[^14]

##### Effect on disease {#CD008736-sec5-0004}

**CL:** Two cluster‐RCTs from Afghanistan and Iran evaluated the effect of ITNs on the incidence of CL ([@CD008736-bbs2-0005]; [@CD008736-bbs2-0011]). In Afghanistan, ITNs impregnated with permethrin (0.5 g/m²) were distributed to all households, and the cumulative analysis of new cases over 15 months showed a marked reduction in CL in areas with ITNs compared to control areas (Intervention 20/1195 (1.7%); control 92/1759 (5.2%); RR 0.32, 95% CI 0.18 to 0.56, one trial, 2954 participants in approximately 600 clusters, [Analysis 2.1](#CD008736-fig-00201){ref-type="fig"}). In Iran, there again appeared to be a large reduction in CL cases. However, the trial authors did not adjust for the cluster design. Our approximate adjustment for clustering in this trial using the ICC from [@CD008736-bbs2-0012] suggests this difference may not reach standard levels of statistical significance (intervention 2/3810 (0.05%); control 117/3815 (3.1%); RR 0.02, 95% CI 0.00 to 1.48, one trial, 7625 participants in 12 clusters, [Analysis 2.1](#CD008736-fig-00201){ref-type="fig"}). In the combined analysis of both trials there was a significant reduction of CL cases.

**VL:** One cluster‐RCT evaluated the effect of PermaNet® ITNs impregnated with deltamethrin (55 mg/m²) on VL in India and Nepal ([@CD008736-bbs2-0010]). The overall risk of VL during the 30 months follow‐up was 37/9829 (0.38%) in the intervention group and 40/9981 (0.40%) in the control group (RR 0.99, 95% CI 0.46 to 2.15, one trial, 19,810 participants in 26 clusters, [Analysis 2.2](#CD008736-fig-00202){ref-type="fig"}). In the same trial, there was also no significant difference in the risk of seroconversion (determined by direct agglutination test) in those who had negative results (titre \< 1:1600) at baseline (RR 0.90, 95% CI 0.49 to 1.65, one trial, 19,810 participants, [Analysis 2.3](#CD008736-fig-00203){ref-type="fig"}).

#### ITCs versus untreated curtains or no curtains {#CD008736-sec4-0015}

(See [Table 3](#CD008736-tbl-0003){ref-type="table"})

##### Effect on vector density {#CD008736-sec5-0005}

One cluster‐RCT evaluated the effect of ITCs on vector density ([@CD008736-bbs2-0009]; [Table 25](#CD008736-tbl-0025){ref-type="table"}). This trial randomized city sectors from urban Venezuela (main vectors: *L. youngi* and *L. ovallesi*) and compared ITCs of lambdacyhalothrin (12.5 mg/m²) with unimpregnated curtains or no curtains. There were no significant differences in mean number of phlebotomine sandflies per house per night between the intervention and control groups before the placement of the curtains (averaged over 150 consecutive nights, January to June 2000; P = 0.706), but the mean was substantially lower in the intervention houses three months after the intervention (P \< 0.001).Table 7Vector density: ITCs versus untreated curtains or no curtains**Trial IDUnit of randomizationInterventionMain vectorMeasure (method)Pre‐interventionPost‐interventionEffect measure (95% CI) or P valueITNsControlITNsControl**[@CD008736-bbs2-0009]City sectorsPolyester curtains impregnated with lambdacyhalothrin (12.5 mg/m²) at 0 and 6 months. The mesh size of curtains was 0.05 mm.*L. youngi* and *L.* *ovallesi*Mean number of sandflies per house\
(light trap in main room of house for 150 nights).15\
(January to June 2000)16\
(January to June 2000)2\
(August to October 2000)17\
(August to October 2000)Pre‐intervention P = 0.706\
Post‐intervention P \< 0.001[^15]

##### Effect on disease {#CD008736-sec5-0006}

**CL:** In [@CD008736-bbs2-0009], over 12 months follow‐up, the incidence of clinical cases of CL was 0/1351 (0%) in the intervention group and 142/1587 (9%) in the control group. The trial authors reported a cluster adjusted mean difference in CL incidence between the intervention and control areas which is statistically significant (MD 8.3, 95% CI 5.0 to 11.7; authors\' own figures). For comparison with other interventions we calculated an approximate RR by using a value of 0.5 events in the intervention group and adjusted for clustering using the ICC from [@CD008736-bbs2-0012] (RR 0.00, 95% CI 0.00 to 0.49, one trial, 2938 participants in 14 clusters, [Analysis 3.1](#CD008736-fig-00301){ref-type="fig"}).

**VL:** No trials evaluated the effects of ITCs on VL incidence.

#### ITS versus no intervention {#CD008736-sec4-0016}

([Table 4](#CD008736-tbl-0004){ref-type="table"})

##### Effect on vector density {#CD008736-sec5-0007}

One cluster‐RCT in areas of Brazil with VL evaluated the effects of treating sheets with lambdacyhalothrin (20 mg/m²) and hanging them near the chicken shed ([@CD008736-bbs2-0008]; [Table 26](#CD008736-tbl-0026){ref-type="table"}). This trial, with main vector *Lu. longipalpis*, randomized chicken sheds but did not provide data to allow us to quantify the magnitude or duration of this effect. The trial authors reported short term reductions in geometric mean phlebotomine sandflies per trap after the intervention, which only differed statistically from control sheds at week 12 post‐intervention.Table 8Vector density: ITS versus no intervention**Trial IDUnit of randomizationInterventionMain vectorMeasure (method)Pre‐interventionPost‐interventionEffect measure (95% CI) or P valueITSControlITSControl**[@CD008736-bbs2-0008]Chicken shedsSheets impregnated with lambdacyhalothrin (20 mg/m²) installed 1 meter from the chicken shed.*Lu. longipalpis*Geometric mean sandflies (light traps)622.3\
(October 1993)404.6\
(October 1993)Not reportedNot reportedThe trial authors state \"the abundance in sheds was approximately 50% below that expected on the first day falling to about 80% at week 12 ‐ the only time the difference was statistically significant\".[^16]

##### Effect on disease {#CD008736-sec5-0008}

**CL:**[@CD008736-bbs2-0011], a cluster‐RCT from Afghanistan, evaluated the effect of treating bedsheets with permethrin (1 g/m²) on CL incidence. In the cumulative analysis of new cases over 15 months follow‐up there were substantially fewer in the intervention households (Intervention 18/1025 (1.8%); control 92/1759 (5.2 %); RR 0.34, 95% CI 0.20 to 0.57, one trial, 2784 participants in approximately 600 clusters, [Analysis 4.1](#CD008736-fig-00401){ref-type="fig"}). The effect appears to be consistent across age groups ([Table 22](#CD008736-tbl-0022){ref-type="table"}).

**VL:** No studies.

#### Insecticide treated uniforms versus no intervention {#CD008736-sec4-0017}

(See [Table 5](#CD008736-tbl-0005){ref-type="table"})

##### Effect on disease {#CD008736-sec5-0009}

**CL:** Two individually randomized trials evaluated the effect of impregnating soldiers uniforms with permethrin on the incidence of CL ([@CD008736-bbs2-0001]; [@CD008736-bbs2-0013]). The trials were small and underpowered to confidently detect or exclude effects. The combined meta‐analysis did not find a statistically significant effect (two trials, 558 participants**,**[Analysis 5.1](#CD008736-fig-00501){ref-type="fig"}). However, in [@CD008736-bbs2-0013] the incidence in the control group was 18/143 over 12 weeks (12%), and just 4/143 (3%) in soldiers with impregnated uniforms which did reach standard levels of statistical significance (RR 0.22, 95% CI 0.08 to 0.64). [@CD008736-bbs2-0001] reported that no side effects occurred, while [@CD008736-bbs2-0013] reported that two out of 229 soldiers with impregnated uniforms had skin irritation and pruritus that required treatment.

**VL:** No trials evaluated the effects of insecticide treated uniforms on VL incidence.

#### Reservoir control versus no intervention {#CD008736-sec4-0018}

##### Effect on disease {#CD008736-sec5-0010}

**VL:** No trials evaluated the effect of reservoir control on clinical disease but one trial from an area endemic with VL in Brazil ([@CD008736-bbs2-0014]) found a 38% reduction in seroconversion over 18 months post‐elimination of infected dogs (RR 0.62, 95% CI 0.42 to 0.91, one trial, 376 participants in 20 clusters, [Analysis 6.1](#CD008736-fig-00601){ref-type="fig"}).

#### Environmental modification (EVM) versus no intervention {#CD008736-sec4-0019}

##### Effect on vector density {#CD008736-sec5-0011}

**VL:** The two cluster‐RCTs in areas of Asia with VL evaluated the effect of EVM on vector density ([Table 27](#CD008736-tbl-0027){ref-type="table"}). Both trials that randomized clusters of houses used trained community mobilizers to promote the filing of cracks in walls and floors with mud or lime ([@CD008736-bbs2-0002]; [@CD008736-bbs2-0007]). Neither trial found evidence of statistically significant reductions in phlebotomine sandflies compared to no intervention up to 12 months follow‐up. Although the variation in measurement and reporting of these outcomes precludes meta‐analysis.Table 9Vector density: EVM versus no intervention**Trial IDUnit of randomizationInterventionMain vectorMeasure (method)Pre‐interventionPost‐interventionEffect measure (95% CI)**\
**or**\
**P valueEVMControlEVMControl**[@CD008736-bbs2-0002]Cluster of 50 housesCommunity mobilizers conducted weekly home visits and educated household members. The major activity was filling cracks and crevices in the walls and floors of human dwellings, detached kitchens, cattle sheds, and other structures such as cattle troughs with mud plaster.*P. argentipes*Total sandflies\
(monthly collections from 40 houses using light traps).662\
(October 2006)683 (October 2006)43\
(January 2007)\
954 (March 2007)54\
(January 2007)\
1219 (March 2007)RR 0.91 (0.31 to 2.63)\
(January 2007)\
RR 0.82 (0.57 to 1.17)\
(March 2007)\
The difference was not statistically significant at any time point up to 12 months[@CD008736-bbs2-0007]Hamlets or neighnourhoodsCommunity mobilizers promoted filling of cracks and crevices in houses and cattle sheds.\
In Nepal and India: wall plastering with lime/mud mixture was promoted (lime was provided free of charge).\
In Bangladesh: wall plastering with mud only (a token incentive was provided) .*P. argentipes*Mean number of sandflies per per house (light trap) per night at all sites pooled in Nepal, Bangladesh and India.13.21\
(date not stated)9.41\
(date not stated)10.39\
(5 months post intervention)12.15\
(5 months post intervention)Pre‐intervention P = 0.108\
Post‐intervention P = 0.503[^17]

##### Effect on disease {#CD008736-sec5-0012}

No trials evaluated the effect of EVM on disease.

#### Multifaceted intervention versus no intervention {#CD008736-sec4-0020}

(See [Table 6](#CD008736-tbl-0006){ref-type="table"})

##### Effect on disease {#CD008736-sec5-0013}

**CL:**[@CD008736-bbs2-0012], a cluster‐RCT from Colombia, evaluated a multifaceted intervention combining ITNs (deltamethrin), personal insect repellent (diethyltoluamide 20%), painting of tree trunks around residences with whitewash, and health education. Over one year follow‐up there was no statistically significant difference in new cases of CL between intervention and control villages (Intervention 10/1791 (0.6%); control 23/1840 (1.3%); RR 0.45, 95% CI 0.13 to 1.50, one trial, 3631 participants in 20 clusters, [Analysis 7.1](#CD008736-fig-00701){ref-type="fig"}), and also no difference in seroconversion (Intervention 82/1066 (7.7%); control 80/1034 (7.7%); RR 0.99, 95% CI 0.51 to 1.95, one trial, 2100 participants in 20 clusters, [Analysis 7.2](#CD008736-fig-00702){ref-type="fig"}). The trial authors reported adverse events in 2% of those in the intervention groups. The most common adverse effects were headache and itching.

**VL:** One additional trial from an area endemic with VL in Brazil ([@CD008736-bbs2-0014]) evaluated IRS plus culling of infected dogs and found no statistically significant difference in seroconversion over 18 months post intervention (Intervention 37/144 (2.6%); control 42/113 (3.7%); RR 0.75, 95% CI 0.51 to 1.11, one trial, 336 participants in 40 clusters, [Analysis 7.2](#CD008736-fig-00702){ref-type="fig"}).

### Section B: Comparisons of different interventions {#CD008736-sec3-0027}

#### IRS versus ITNs, ITCs or ITS {#CD008736-sec4-0021}

(See [Table 7](#CD008736-tbl-0007){ref-type="table"})

##### Effect on vector density {#CD008736-sec5-0014}

Two cluster‐RCTs in areas of Asia with VL evaluated the comparative effect of IRS and ITNs (55 mg/m² deltamethrin) on vector density ([Table 28](#CD008736-tbl-0028){ref-type="table"}). In a trial from Bangladesh, India and Nepal, [@CD008736-bbs2-0007], the pooled data with a follow‐up at five months on trapped phlebotomine sandflies (*P. argentipes*) in houses showed that IRS was effective with an average sandfly reduction of about 50%, but the ITNs had very little effect. In the other trial from Bangladesh, [@CD008736-bbs2-0002], both interventions were associated with an overall decrease in total sandfly (*P. argentipes*) density at five months. The variation in measurement and reporting of these outcomes precludes meta‐analysis.Table 10Vector density: IRS versus ITNs**Trial IDIntervention 1/Intervention 2Main vectorMeasure (method)Pre‐interventionPost‐interventionsP valueIRSITNIRSITN**[@CD008736-bbs2-0002]**IRS** with 20 mg/per m² deltamethrin.\
versus\
**ITN** PermaNet® 2.0 distributed to all households in November 2006*P. argentipes*Total sandflies\
(monthly collections from 40 houses using light traps).633 (October 2006)724\
(October 2006)644\
(October 2007)189\
(October 2007)Not reported[@CD008736-bbs2-0007]**IRS**\
Bangladesh: 20 mg/m²deltamethrin.\
India: 1 g/m² 5% DDT\
Nepal: 0.025 g/ m² alpha‐cypermethrin\
versus\
**ITN** PermaNet® distributed to all households (date not stated),*P. argentipes*Mean number of sandflies per per house (light trap) per night at all sites pooled in Nepal, Bangladesh and India.12.32\
(date not stated)9.92\
(date not stated)6.14\
(5 months post intervention)8.32\
(5 months post intervention)Not reported[^18]

[@CD008736-bbs2-0008], a cluster‐RCT in areas of Brazil with VL, included a comparison of IRS with insecticide‐impregnated (20 mg/m² lambdacyhalothrin) cotton sheets or blankets (focal coverage) ([Table 29](#CD008736-tbl-0029){ref-type="table"}). Following IRS intervention, *Lu.longipalpis* abundance fell by only 45% versus 90% after ITS intervention on week 12 post‐intervention.Table 11Vector density: IRS versus ITS**Trial IDIntervention 1/Intervention 2Main vectorMeasure (method)Pre‐interventionPost‐interventionP valueIRSITSIRSITS**[@CD008736-bbs2-0008]**IRS** with 20 mg/m² of 10% lambdacyhalothrin.\
versus\
**ITS** with 20 mg/m² of lambdacyhalothrin installed c. 1 m from the roost.*Lu. longipalpis*Ln Odds Ratio (IRS:ITS)In sheds which were to be sprayed. Geometric mean abundance of *Lu. longipalpis* (males + females): 1132.3\
(1 to 2 pre‐intervention trapping rounds were conducted from 16 October to 11 November 1993)In sheds wich were to receive targets sheets. Geometric mean abundance of *Lu. longipalpis* (males + females): 622.3\
(1 to 2 pre‐intervention trapping rounds were conducted from 16 October to 11 November 1993)0.23\
Sheds, time range not reported\
(x^2^ = 6.12). 90% reduction in *Lu.longipalpis* abundance\
Dining‐huts, not reported\
Houses, not reportedMeasured as Ln Odds ratio (IRS:ITS)\
Following blanket intervention, the abundance of *Lu. longipalpis* in traps fell by 45% (not significant).\
Catches at untreated dining‐huts actually increased, possibly because the blanket coverage diverted *Lu. longipalpis* away from major aggregation sites at animal pens.\< 0.025[^19]

##### Effect on disease {#CD008736-sec5-0015}

**CL:** In the multi‐arm cluster‐RCT from Afghanistan, [@CD008736-bbs2-0011], the differences in CL incidence between clusters allocated to IRS, ITNs or ITS did not reach standard levels of statistical significant differences among interventions over 15 months (IRS versus ITNs, RR 1.9, 95% CI 0.98 to 3,69 [Analysis 8.1](#CD008736-fig-00801){ref-type="fig"}; IRS versus ITS, RR 1.83 95% CI 0.92 to 3.64 [Analysis 9.1](#CD008736-fig-00901){ref-type="fig"}; and ITNs versus ITS, RR 0.96 95% CI 0.45 to 2.08 [Analysis 10.1](#CD008736-fig-01001){ref-type="fig"}; one trial, 3353 participants in approximately 600 clusters).

**VL:** No trials evaluated the effect of this comparison on VL incidence.

#### IRS versus EVM {#CD008736-sec4-0022}

##### Effect on vector density {#CD008736-sec5-0016}

Two cluster‐RCTs in areas of Asia with VL also evaluated the effect of IRS versus EVM on vector density ([@CD008736-bbs2-0002]; [@CD008736-bbs2-0007]; [Table 30](#CD008736-tbl-0030){ref-type="table"}). The pooled data in both trials showed that EVM had no or very little effect on total sandfly (*P. argentipes*) density at five months but the variation in measurement and reporting of these outcomes precludes meta‐analysis.Table 12Vector density: IRS versus EVM**Trial IDIntervention 1/Intervention 2Main vectorMeasure (method)Pre‐interventionPost‐interventionP valueIRSEVMIRSEVM**[@CD008736-bbs2-0002]**IRS** with 20 mg/per m² deltamethrin.\
versus\
**EVM**\
Filling cracks and crevices in the walls and floors of human dwellings, detached kitchens, cattle sheds, and other structures. Promotion of cleaning up debris from the environment using household incentives.*P. argentipes*Total sandflies\
(monthly collections from 40 houses using light traps).633\
(October 2006)662\
(October 2006)644\
(October 2007)598\
(October 2007)Not reported[@CD008736-bbs2-0007]**IRS**\
Bangladesh: 20 mg/m² deltamethrin.\
India: 1 g/m² 5% DDT\
Nepal: 0.025 g/m² alpha‐cypermethrin.\
versus\
**EVM**\
Trained community mobilizers met with each family to discuss the typical resting and breeding sites in and around the houses and the appropriate ways to reducing them. In Nepal and India wall plastering with lime/mud mixture was promoted, the lime being provided free of charge to the households. In Bangladesh plastering was done with mud only.*P. argentipes*Mean number of sandflies per per house (light trap) per night at all sites pooled in Nepal, Bangladesh and India.12.32\
(date not stated)13.21\
(date not stated)6.14\
(5 months post intervention)10.39\
(5 months post intervention)Not reported[^20]

##### Effect on disease {#CD008736-sec5-0017}

No trials evaluated the effect of this comparison on leishmaniasis.

#### ITNs vs EVM {#CD008736-sec4-0023}

##### Effect on vector density {#CD008736-sec5-0018}

Two cluster‐RCTs in areas of Asia with VL also compared long‐lasting ITN with EVM ([@CD008736-bbs2-0002]; [@CD008736-bbs2-0007]; [Table 31](#CD008736-tbl-0031){ref-type="table"}). Only ITNs had an important effect on the average reduction of phlebotomine sandflies (*P. argentipes*) at five months. The variation in measurement and reporting of these outcomes precludes meta‐analysis.Table 13Vector density: ITNs versus EVM**Trial IDIntervention 1/Intervention 2Main vectorMeasure (method)Pre‐interventionPost‐interventionP valueITNsEVMITNsEVM**[@CD008736-bbs2-0002]**ITNs** PermaNet® made of polyester containing deltamethrin (55 mg/m²)\
versus\
**EVM**\
Filling cracks and crevices in the walls and floors of human dwellings, detached kitchens, cattle sheds, and other structures. Promotion of cleaning up debris from the environment using household incentives.*P. argentipes*Total sandflies\
(monthly collections from 40 houses using light traps)724 (October 2006)662\
(October 2006)18\
(January 2007)\
361 (March 2007)598\
(October 2007)Not reported[@CD008736-bbs2-0007]**ITNs** PermaNet® made of polyester containing deltamethrin (55 mg/m²).\
versus\
**EVM**\
Trained community mobilizers met with each family to discuss the typical resting and breeding sites in and around the houses and the appropriate ways to reducing them. In Nepal and India wall plastering with lime/mud mixture was promoted, the lime being provided free of charge to the households. In Bangladesh plastering was done with mud only.*P. argentipes*Mean number of sandflies per house (light trap) per night at all sites pooled in Nepal, Bangladesh and India.9.92\
(date not stated)13.21\
(date not stated)8.32\
(5 months post intervention)10.39\
(5 months post intervention)Not reported[^21]

##### Effect on disease {#CD008736-sec5-0019}

No trials evaluated the effect of this comparison on leishmaniasis.

#### Reservoir control versus IRS {#CD008736-sec4-0024}

##### Effect on disease {#CD008736-sec5-0020}

**VL:**[@CD008736-bbs2-0003], a cluster‐RCT based in a VL‐endemic area in Brazil (367 inhabitants; 213 seronegatives), evaluated the effects of insecticide spraying of animal pens, and reservoir control (eliminating infected dogs) on seroconversion, using IRS of houses alone as the control group. Trial authors did not present the total number of participants in each of the four intervention groups.

IRS of houses and elimination of infected dogs appeared to reduce seroconversion compared to IRS alone (RR 0.20, 95% CI 0.05 to 0.85, one trial, number of participants not available, [Analysis 11.1](#CD008736-fig-01101){ref-type="fig"}). However, this effect was not seen in a similar comparison of IRS of houses and animal pens plus elimination of infected dogs versus IRS alone (RR 0.69, 95% CI 0.27 to 1.76, one trial, number of participants not available, [Analysis 11.1](#CD008736-fig-01101){ref-type="fig"}).

Discussion {#CD008736-sec1-0006}
==========

Summary of main results {#CD008736-sec2-0010}
-----------------------

We included 14 RCTs that evaluated a range of interventions across different settings. All included trials were at high or unclear risk of selection or reporting bias.

In a single trial from Afghanistan ([@CD008736-bbs2-0011]) spraying the internal walls of houses with insecticide reduced CL incidence by about a third (*low quality evidence*), see [Table 1](#CD008736-tbl-0001){ref-type="table"}. In two trials from Afganistan and Iran ([@CD008736-bbs2-0011][@CD008736-bbs2-0005]) ITNs reduced the incidence by around two thirds (*low quality evidence*), see [Table 2](#CD008736-tbl-0002){ref-type="table"}. However, in direct comparisons between these interventions ([@CD008736-bbs2-0011]), the difference was not statistically significant (*low quality evidence*), see [Table 7](#CD008736-tbl-0007){ref-type="table"}. In one additional trial from Venezuela ([@CD008736-bbs2-0009]), ITCs almost completely prevented CL (*low quality evidence*), see [Table 3](#CD008736-tbl-0003){ref-type="table"}; and in one trial from Brazil ([@CD008736-bbs2-0008]), ITS reduced the incidence by around two thirds (*low quality evidence*), see [Table 4](#CD008736-tbl-0004){ref-type="table"}.

Two small trials in soldiers evaluated personal protection for CL by using insecticide treated clothing ([@CD008736-bbs2-0001]; [@CD008736-bbs2-0013]). Although there was a statistically significant effect in one trial ([@CD008736-bbs2-0013]), they were both underpowered to reliably evaluate the effects (*low quality evidence*), see [Table 5](#CD008736-tbl-0005){ref-type="table"}.

Only ITNs have been evaluated for an effect on VL incidence. A single trial from India and Nepal reported no effect ([@CD008736-bbs2-0010]) (*moderate quality evidence*), see [Table 2](#CD008736-tbl-0002){ref-type="table"}.

Two trials from Brazil evaluated the effects of culling infected dogs versus no intervention or IRS ([@CD008736-bbs2-0003][@CD008736-bbs2-0014]). They reported a reduction in seroconversion over 18 months follow‐up but did not measure or report effects on clinical diseases.

Some included trials evaluated vector density. Four trials ([@CD008736-bbs2-0002]; [@CD008736-bbs2-0007]; [@CD008736-bbs2-0008]; [@CD008736-bbs2-0006]) reported reductions in sandfly abundance after spraying (*moderate quality evidence*). Two trials ([@CD008736-bbs2-0002]; [@CD008736-bbs2-0005]) found a reduction in vector density after use of ITNs, while another two ([@CD008736-bbs2-0007]; [@CD008736-bbs2-0004]) did not (*low quality evidence*). In one trial ([@CD008736-bbs2-0009]), vector density was substantially lower after using ITCs (*low quality evidence*).

Overall completeness and applicability of evidence {#CD008736-sec2-0011}
--------------------------------------------------

In this Cochrane Review, most evidence relates to the use of insecticide to reduce phlebotomine sandfly numbers and prevent CL. When taken as a body of evidence, this appears to be an effective strategy to reduce clinical disease. However, as only one or two trials evaluated each individual intervention (applying insecticide to indoor walls, bednets, bed sheets or curtains), it is unclear which is the best strategy.

Importantly, although insecticide use appears to be effective, we found no evidence from RCTs on the safety or environmental impact of insecticides used in this way. Policy makers should consider evidence from other sources when considering safety in their decisions.

Furthermore, included trials with clinical outcomes were from only a limited number of epidemiological settings (Afghanistan, Iran, India, Nepal, Venezuela, Colombia and Brazil); and this limits our ability to make broad generalizations. The epidemiology of leishmaniasis is extremely complex not only because of the different *Leishmania* species, vectors and reservoirs, but also because the extreme diversity in human behaviour and settings. For example, annual and seasonal differences in the breeding and resting habits of infected phlebotomine sandflies, coupled with differences in the work and recreational habits of humans are likely to affect the efficacy of preventive measures across settings and cultures. IRS is only considered likely to be effective where infected phlebotomine sandflies are endophilic and the effectiveness of ITNs is considered dependent on the local behaviour of both humans and infected phlebotomine sandflies.

For VL, the evidence is much more limited, due in part to it being a relatively rare disease which would require extremely large trials to demonstrate an effect. Extrapolation of results from CL to VL is likely to be unreliable given the differences in ecological habitats and geographical locations.

This Cochrane Review also highlights that some widely used interventions have very little evidence to support their use. There is only a limited evidence base for the use of insecticide‐treated clothing for protection against CL transmission despite having been used for many years by the military and in recreational activities as personal protection against bites. Although frequently used, cheap and easily available, insect repellents for personal protection against sandfly bites in endemic areas, including chemical agents or local vegetal oils ([@CD008736-bbs2-0042]; [@CD008736-bbs2-0051]), were not assessed in any of the included trials. Very limited evidence is also available on the effect of environmental management and modification aimed to impede phlebotomine sandflies from breeding. The WHO recommends that sandfly control involve more than one method in an integrated vector management approach ([@CD008736-bbs2-0063]) but only one trial with limitations in quality studied a multifaceted intervention combining ITNs, personal insect repellent, painting of tree trunks around residences and health education ([@CD008736-bbs2-0012]).

The low number of included trials unfortunately prevented us from conducting any subgroup analyses, which would have enabled analysis of the impact of different types of insecticides, resistance to insecticides, the transmission seasons and vector ecology.

Although not all included trials examined the acceptability and compliance of the interventions, low compliance and acceptability can represent potential limitations of the included trials.

Quality of the evidence {#CD008736-sec2-0012}
-----------------------

We judged the evidence for CL reduction with the individual interventions (ITNs, ITS, ITCs or IRS) to be of moderate or low quality. This means that we have some confidence in these estimates of effect but further research is warranted.

Two main reasons led us to downgrade the evidence. Firstly, descriptions of trial methods was vague for almost all included trials and so the risk of bias was unclear, Secondly, the main evidence was from just three trials (from Afghanistan, Venezuela and Iran), which makes broad generalization to different epidemiological settings and cultures difficult. To have full confidence that these interventions are widely effective requires further well‐conducted trials from different settings.

Only one trial evaluated the protective effect of ITNs against VL and found this intervention to be ineffective ([@CD008736-bbs2-0010]) and we judged the evidence to be of moderate quality.

Potential biases in the review process {#CD008736-sec2-0013}
--------------------------------------

We did not identify any specific bias in our review process.

Agreements and disagreements with other studies or reviews {#CD008736-sec2-0014}
----------------------------------------------------------

A systematic review of RCTs and other controlled studies on preventative methods against human leishmaniasis ([@CD008736-bbs2-0059]; [@CD008736-bbs2-0060]) was published during the development of this Cochrane Review. The authors\' main conclusions also highlight the lack of high quality evidence centred in clinical outcomes and the inability to generalize the findings across different geographic areas and settings. However, a more precise mapping of the best evidence was limited because the inclusion of non‐randomized studies and the lack of a methodological quality assessment of studies.

[@CD008736-bbs2-0058], a systematic review on VL control in Latin‐America, added that lack of political commitment and the weakness of case management and surveillance systems are important limitations for VL elimination.

Authors\' conclusions {#CD008736-sec1-0007}
=====================

Using insecticides to reduce phlebotomine sandfly numbers appears to be effective at reducing CL incidence in some settings. However, there is insufficient evidence to know whether it is better to spray the internal walls of houses or to use insecticide impregnated bednets, curtains, bedsheets or clothing. There is currently no evidence that these measures are effective or not in reducing VL incidence.Policy decisions should consider local sandfly epidemiology and behaviour, as well as the diversity of transmission scenarios (including vector and animal or human reservoirs) when designing and implementing leishmaniasis control programmes.Resources are limited for clinical research into neglected diseases, including leishmaniasis. Therefore, there appropriately designed and adequately powered trials are needed. Given the link between a reduction in phlebotomine sandfly populations and a consequent reduction in cases of leishmaniasis is neither guaranteed or proven, future trials of promising interventions should directly assess the effect on reduction in cases of leishmaniasis. The use of standard guidelines, as performed for other leishmaniasis reviews ([@CD008736-bbs2-0045]), may help to resolve these issues. In the case of cluster‐RCTs it is very important to obtain specialist statistical advice throughout the entire process of planning, conducting and analysing the trials ([@CD008736-bbs2-0037]).Adequate exploration and reporting of acceptability and compliance of intervention measures is crucial for the correct interpretation of the results assessing preventive measures, otherwise results may not be significant for the main objective of the study.Given the constraints of IRS, it is worth further exploring the use, effect and impact of insecticide treated materials, particularly long lasting insecticide treated clothes and ITNs. The gap of RCTs in vector control measures in Africa is remarkable. There is also a need for testing the use of different types of insecticide and their impact in different geographical areas. We have found some additional areas of uncertainty that need to be explored in future trials:Strategies of EVM.Multifaceted interventions.Integrated vector management strategies based on understanding the local resources.Human and animal (domestic and wild) reservoir control (for example, impregnated dog collars or lotions, poisonous baits for rodents eating seeds, removal of plants for rodents which feed on them, vaccines for canine leishmaniasis, destruction of burrows, trapping).

The academic editor for this review was Professor Paul Garner.

We acknowledge María Ángeles Mora and Rosa Amill (Roche Farma, Scientific Information) for bibliographical support; and Cristina Martinez and Natalia Mendoza for help in the early development of this Cochrane Review. Also, we thank Paul Garner and CIDG editorial staff for assistance editing the review at various stages. This Cochrane Review is funded by a grant from the Office of Control of Neglected Tropical Diseases (WHO/CDS/NTD/IDM), Communicable Diseases Cluster, WHO. It has been supported in part by the Agencia Española de Cooperación Internacional para el Desarrollo (AECID). The editorial base of the CIDG is funded by the UK Department for International Development (DFID) for the benefit of low‐ and middle‐income countries.
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Comparison 1IRS versus no interventionOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 CL cases](#CD008736-fig-00101){ref-type="fig"}Analysis 1.1Comparison 1 IRS versus no intervention, Outcome 1 CL cases.1Risk Ratio (Fixed, 95% CI)Subtotals only1.1 8 months after intervention12943Risk Ratio (Fixed, 95% CI)0.47 \[0.23, 0.99\]1.2 10 months after intervention12954Risk Ratio (Fixed, 95% CI)0.42 \[0.23, 0.78\]1.3 15 months after intervention12892Risk Ratio (Fixed, 95% CI)0.61 \[0.38, 0.97\][2 Seroconversion (Montenegro Skin Test)](#CD008736-fig-00102){ref-type="fig"}Analysis 1.2Comparison 1 IRS versus no intervention, Outcome 2 Seroconversion (Montenegro Skin Test).1295Risk Ratio (Fixed, 95% CI)0.86 \[0.63, 1.17\]2.1 18 months after intervention1295Risk Ratio (Fixed, 95% CI)0.86 \[0.63, 1.17\]

Comparison 2ITNs versus no interventionOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 CL cases](#CD008736-fig-00201){ref-type="fig"}Analysis 2.1Comparison 2 ITNs versus no intervention, Outcome 1 CL cases.2Risk Ratio (Fixed, 95% CI)Subtotals only1.1 8 months after intervention13142Risk Ratio (Fixed, 95% CI)0.31 \[0.15, 0.66\]1.2 10 months after intervention13092Risk Ratio (Fixed, 95% CI)0.35 \[0.20, 0.64\]1.3 \> 12 months after intervention210579Risk Ratio (Fixed, 95% CI)0.31 \[0.18, 0.53\][2 VL cases](#CD008736-fig-00202){ref-type="fig"}Analysis 2.2Comparison 2 ITNs versus no intervention, Outcome 2 VL cases.119810Risk Ratio (Fixed, 95% CI)0.99 \[0.46, 2.15\][3 Seroconversion](#CD008736-fig-00203){ref-type="fig"}Analysis 2.3Comparison 2 ITNs versus no intervention, Outcome 3 Seroconversion.119810Risk Ratio (Random, 95% CI)0.90 \[0.49, 1.65\]

Comparison 3ITC versus untreated curtains or no curtainsOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 CL cases](#CD008736-fig-00301){ref-type="fig"}Analysis 3.1Comparison 3 ITC versus untreated curtains or no curtains, Outcome 1 CL cases.12938Risk Ratio (Fixed, 95% CI)0.00 \[0.00, 0.49\]

Comparison 4ITS versus no interventionOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 CL cases](#CD008736-fig-00401){ref-type="fig"}Analysis 4.1Comparison 4 ITS versus no intervention, Outcome 1 CL cases.1Risk Ratio (Random, 95% CI)Subtotals only1.1 8 months after intervention12918Risk Ratio (Random, 95% CI)0.45 \[0.25, 0.82\]1.2 10 months after intervention12847Risk Ratio (Random, 95% CI)0.36 \[0.19, 0.68\]1.3 15 months after intervention12784Risk Ratio (Random, 95% CI)0.34 \[0.20, 0.57\]

Comparison 5Insecticide treated uniforms versus no interventionOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 CL cases](#CD008736-fig-00501){ref-type="fig"}Analysis 5.1Comparison 5 Insecticide treated uniforms versus no intervention, Outcome 1 CL cases.2558Risk Ratio (M‐H, Random, 95% CI)0.40 \[0.13, 1.20\]

Comparison 6Reservoir control versus no interventionOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 Serconversion (Montenegro Skin Test)](#CD008736-fig-00601){ref-type="fig"}Analysis 6.1Comparison 6 Reservoir control versus no intervention, Outcome 1 Serconversion (Montenegro Skin Test).1Risk Ratio (Fixed, 95% CI)Subtotals only1.1 18 months after intervention1376Risk Ratio (Fixed, 95% CI)0.62 \[0.42, 0.91\]

Comparison 7Multifaceted intervention versus no interventionOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 CL cases](#CD008736-fig-00701){ref-type="fig"}Analysis 7.1Comparison 7 Multifaceted intervention versus no intervention, Outcome 1 CL cases.13631Risk Ratio (Fixed, 95% CI)0.45 \[0.13, 1.50\][2 Seroconversion](#CD008736-fig-00702){ref-type="fig"}Analysis 7.2Comparison 7 Multifaceted intervention versus no intervention, Outcome 2 Seroconversion.22436Risk Ratio (Fixed, 95% CI)0.80 \[0.57, 1.13\]

Comparison 8IRS versus ITNsOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 CL cases](#CD008736-fig-00801){ref-type="fig"}Analysis 8.1Comparison 8 IRS versus ITNs, Outcome 1 CL cases.1Risk Ratio (Random, 95% CI)Subtotals only1.1 8 months after intervention11672Risk Ratio (Random, 95% CI)1.52 \[0.44, 5.32\]1.2 10 months after intervention11677Risk Ratio (Random, 95% CI)1.17 \[0.53, 2.60\]1.3 15 months after intervention11655Risk Ratio (Random, 95% CI)1.90 \[0.98, 3.69\]

Comparison 9IRS versus ITSOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 CL cases](#CD008736-fig-00901){ref-type="fig"}Analysis 9.1Comparison 9 IRS versus ITS, Outcome 1 CL cases.1Risk Ratio (Random, 95% CI)Subtotals only1.1 8 months after intervention1Risk Ratio (Random, 95% CI)1.05 \[0.29, 3.84\]1.2 10 months after intervention1Risk Ratio (Random, 95% CI)1.17 \[0.50, 2.71\]1.3 15 months after intervention1Risk Ratio (Random, 95% CI)1.83 \[0.92, 3.64\]

Comparison 10ITNs versus ITSOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 CL cases](#CD008736-fig-01001){ref-type="fig"}Analysis 10.1Comparison 10 ITNs versus ITS, Outcome 1 CL cases.1Risk Ratio (Fixed, 95% CI)Subtotals only1.1 8 months after intervention1Risk Ratio (Fixed, 95% CI)0.69 \[0.26, 1.81\]1.2 10 months after intervention1Risk Ratio (Fixed, 95% CI)1.00 \[0.42, 2.34\]1.3 15 months after intervention1Risk Ratio (Fixed, 95% CI)0.96 \[0.45, 2.08\]

Comparison 11Reservoir control versus IRSOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 Seroconversions](#CD008736-fig-01101){ref-type="fig"}Analysis 11.1Comparison 11 Reservoir control versus IRS, Outcome 1 Seroconversions.1Risk Ratio (Fixed, 95% CI)0.56 \[0.30, 1.02\]1.1 IRS of houses and animal pens versus IRS of houses1Risk Ratio (Fixed, 95% CI)0.69 \[0.27, 1.76\]1.2 IRS of houses and culling infected dogs versus IRS of houses1Risk Ratio (Fixed, 95% CI)0.20 \[0.05, 0.85\]1.3 IRS of houses and animal pens and culling infected dogs versus IRS of houses1Risk Ratio (Fixed, 95% CI)0.69 \[0.27, 1.76\]

We changed the primary outcome from \"Reduction (%) of cases (incidence) of leishmaniasis\" in [@CD008736-bbs2-0064] to \"cases of leishmaniasis\".

Characteristics of included studies \[ordered by study ID\] {#CD008736-sec2-0027}
===========================================================

[@CD008736-bbs2-0001]MethodsTrial design: Doubled‐blind, placebo‐controlled RCT.\
Unit of randomization: A soldier.\
Number of participants: 324 male soldiers (162 each group).\
Entomological data collection: Not performed.\
Clinical data collection: All soldiers were visited monthly. CL diagnosis was confirmed in every suspected lesion parasitologically using Giemsa‐stained direct smears. If amastigotes were not seen, the lesion was biopsied.\
Follow‐up: 6 months.\
Analysis: Analysed at individual level.ParticipantsMale soldiers, aged 19 to 21 years, with no history of leishmaniasis or any evidence of active CL.\
**Endemic disease: CL** (no mention of the*Leishmania* species involved).InterventionsPermethrin‐impregnated uniforms (shirt, undershirt, pants, socks and hat; with a permethrin concentration of 850 mg/m² of clothing), for 3 months.Control uniforms (shirt, undershirt, pants, socks and hat were soaked in water that did not contain permethrin), for 3 months.OutcomesNumber of new cases of leishmania, assessed at 6 months.Adverse‐effects, such as contact dermatitis, were not observed in any soldiers.NotesCountry: Iran (area of Isfahan).\
Trial dates: June 2001 to September 2001.\
Trial sponsor: Not reported.\
Sample size calculation: Not calculated.\
Compliance assessment: Done. Soldiers were instructed not to use insect repellents and other protective measures, and adherence to these instructions was monitored. The uniforms covered the whole body except for the head, neck, hands and feet.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskInsufficient detail was reported about the method used to generate the allocation sequence. \"A total of 324 soldiers were randomly divided into two groups\".Allocation concealment (selection bias)High riskNot reported.Blinding (performance bias and detection bias) participantsUnclear riskParticipants were blinded but with no detail of the method used for it. \"The uniforms were distributed in such a way that neither the soldier nor the researcher knew as to which uniform were permethrin‐impregnated\".Blinding (performance bias and detection bias) investigatorsUnclear riskInvestigators were blinded but with no detail of the method used for it. \"The uniforms were distributed in such a way that neither the soldier nor the researcher knew as to which uniform were permethrin‐impregnated\".Blinding (performance bias and detection bias) AssessorsUnclear riskNot reported.Incomplete outcome data (attrition bias) All outcomesHigh riskITT analysis was not used. Intervention: 28 dropouts (the reasons for dropouts were not reported). Control: 24 dropouts (the reasons for dropouts were not reported).Selective reporting (reporting bias)Low riskAll outcomes mentioned in the methods were reported in the results.Baseline measurementsHigh riskNo baseline characteristics by group.Statistical adjustment for clusteringLow riskNot applicable as this trial was individually randomized.Other biasUnclear riskTrial authors did not provide a conflict of interest declaration.\
They did not take into account the activities of soldiers during day and night, or where they slept.[@CD008736-bbs2-0002]MethodsTrial design: Cluster‐RCT.\
Unit of randomization: 5 households.\
Number of clusters: 6.\
Entomological data collection: Adult sandfly density was determined in households sampled monthly by counts of vectors either landing rates on exposed body parts of humans acting as baits or collected resting inside buildings (for example, walls).\
Clinical data collection: Not done.\
Length of follow‐up: 12 months.\
Analysis: Analysed at household level.ParticipantsFour villages were divided into six geographical areas with high, intermediate or low density of phlebotomine sandflies. Five households were selected from each of the density areas by simple random sampling, yielding a subset of (24 X 5) 120 households that participated in the trial. The assignment to intervention arms was stratified by the average vector density to provide comparable vector density distribution in each arm.\
**Endemic disease: VL caused by *L. donovani.***InterventionsIRS using deltamethrin (K‐Otrine 5%, Aventis Bayer company, target concentration 20 mg/m²).Long‐lasting insecticide treated nets type PermaNet® 2.0 nets (second generation, Vestergaard Frendsen Lousanne) made of polyester containing deltamethrin (55 mg/m²).EVM. Community mobilizers conducted weekly home visits and educated household members. The major activity was filling cracks and crevices in the walls and floors of human dwellings, detached kitchens, cattle sheds and other structures, such as cattle troughs with mud plaster. In addition, the team promoted cleaning up debris from the environment. Household incentives were offered, consisting of a pen, pencil and notebook for children attending school, or soap if there were no schoolchildren in the household.OutcomesMean number of phlebotomine sandflies trapped per household for 12 months.NotesCountry: Bangladesh (Fulbaria subdistrict, Mymensingh district).\
Trial dates: October 2006 to September 2007. Unclear timing and duration of interventions.\
Trial sponsor: Funded by a grant from the Centers for Disease Control and Prevention (CDC) Emerging Infections Initiative and by the Special Programme for Research and Training in Tropical Diseases, WHO.\
Sample size: Calculated.\
Compliance assessment: Done. Houses were visited monthly to encourage compliance.\
This trial is 1 of 4 parallel trials in India, Nepal, and Bangladesh that used similar methods and design ([@CD008736-bbs2-0007]).***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskInsufficient detail was reported about the method used to generate the allocation sequence.Allocation concealment (selection bias)Unclear riskNot reported.Blinding (performance bias and detection bias) participantsUnclear riskPeople not assessed in this trial.Blinding (performance bias and detection bias) investigatorsUnclear riskNot reported.Blinding (performance bias and detection bias) AssessorsUnclear riskNot reported.Incomplete outcome data (attrition bias) All outcomesUnclear riskNo information on loss of clusters. Individual participants were not followed up.Selective reporting (reporting bias)Low riskAll outcome mentioned in the methods were reported in the results.Baseline measurementsLow riskAssignment to intervention arms were stratified by vector density.Statistical adjustment for clusteringLow riskThe outcome was rates of phlebotomine sandflies trapped, and the statistical model used a random effect which accounted for clustering within households.Other biasUnclear riskTrial authors did not provide a conflict of interest declaration.[@CD008736-bbs2-0003]MethodsTrial design: Cluster‐RCT.\
Unit of randomization: Geographic area.\
Number of clusters: 34 geographic areas.\
Entomological data collection: Not done.\
Clinical data collection: Immunological tests by ELISA in blood samples to detect antigen from *Leishmania chagasi, a*t one year.\
Length of follow‐up: 6 to 12 months.\
Analysis: Analysed at cluster level.ParticipantsThe central area of Teresina (Brazil) was divided in 34 geographic areas (blocks) randomly allocated to the 4 types of interventions (367 inhabitants; 213 seronegatives/154 seropositives at the beginning).\
**Endemic disease: VL caused by *L. infantum (L. chagasi).***InterventionsSpraying houses and animals pens with insecticide.Spraying houses and eliminating infected dogs.Combination of spraying houses and animal pens and eliminating infected dogs.Spraying houses (considered as no treatment in the publication).\
Description of spraying: Pyrethroid insecticide in internal walls (all of 3 m height walls were sprayed) of houses (household spraying) and outdoors close to the houses.\
The elimination of infected dogs was decided if indirect immunofluorescence test was more or equalled 1:40.OutcomesCases of seropositivity by ELISA assessed at one year.NotesCountry: Brazil (Teresina, Itararé quarter).\
Trial dates: 1995 to 1996.\
Trial sponsor: No source of funding reported.\
Sample size: Not calculated.\
Compliance assessment: Not reported.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskInsufficient detail was reported about the method used to generate the allocation sequence. \"Os lotes foram alocados aleatoriamente a 4 tipos de intervenção\".Allocation concealment (selection bias)Unclear riskNot reported.Blinding (performance bias and detection bias) participantsUnclear riskNot reported.Blinding (performance bias and detection bias) investigatorsUnclear riskNot reported.Blinding (performance bias and detection bias) AssessorsUnclear riskNot reported.Incomplete outcome data (attrition bias) All outcomesHigh riskNo information on loss of clusters. There were 44% of lost of participants to follow‐up (93/213) although the authors did not specify to which group these people belonged.Selective reporting (reporting bias)Low riskAll outcomes mentioned in the methods were reported in the results.Baseline measurementsHigh riskThe prevalence of seropositivity at baseline were similar in the intervention areas but was significantly lower in the control area (only IRS). Groups were not comparable at baseline. Prevalence of infection was similar within the three treatments, but not between the treatments and the control group (lower prevalence in control group).Statistical adjustment for clusteringLow riskCluster adjustment was performed as the model considered the effect of aggregation of individuals in batches and used robust variance estimates.Other biasUnclear riskTrial authors did not provide a conflict of interest declaration.[@CD008736-bbs2-0004]MethodsTrial design: Paired RCT.\
Unit of randomization: Houses.\
Number of houses: 48.\
Entomological data collection: Cross‐sectional surveys using one CDC light trap per house. Collection was one night (6pm to 6am) at baseline (week 0), and then at 3, 6 and 9 weeks after net installation.\
Clinical data collection: Not done.\
Length of follow‐up: 9 weeks.\
Analysis: Analysed at household level.ParticipantsThree hamlets in Bihar, India (Gulmehiya Bagh in Patna district, and Rasoolpur and Majlishpur, both located in Vaishali district) were selected for this trial. In each hamlet, 16 houses were selected: 8 human dwellings without cattle inside the house but with cattle within the compound and 8 mixed dwellings where cattle and humans were sharing the same roof. For both types of houses and in each hamlet, 2 houses were allocated to 1 of the 4 treatments).\
**Endemic disease: VL caused by *L. donovani.***\
Main vector and seasonality: *P. argentipes* has well‐defined seasonal patterns with a peak from March to May, and a second lower peak in November.InterventionsThree nets were distributed to each house after the baseline survey:\
Olyset® ITN: Polyethelene wide mesh net (4 mm X 4 mm), impregnated with permethrin (2%).PermaNet® 2.0 ITN: Polyester net with small meshes (25 holes/cm²) impregnated with deltamethrin (55 mg/m²).Control: Untreated locally made polyester nets (25 holes/cm²).Control: Untreated PermaNet® 2.0.\
During the trial period, the 3 hamlets were sprayed with DDT by the Governmental Control Programme at a dosage of 1 g active ingredient/m², between surveys 1 and 2.OutcomesGeometric mean sandfly counts per group at baseline, 3, 6 and 9 weeks post‐intervention.NotesCountry: India.\
Trial dates: April to June 2006.\
Trial sponsor: the European Union, the Indian Council of Medical Research, the Government of India Health and Family Welfare, New Delhi. The CDC light traps purchase was sponsored by Mr Guy Deckers (Konhef, Belgium).\
Sample size: Not calculated.\
Compliance assessment: Not reported.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskInsufficient detail was reported about the method used to generate the allocation sequence. \"In each hamlet, 16 houses were purposively selected: eight human dwellings without cattle inside the house but with cattle within the compound and eight mixed dwellings where cattle and humans are sharing the same roof. For both the categories and in each hamlet, two houses were randomly allocated to one of the four treatments.\"Allocation concealment (selection bias)Unclear riskNot reported.Blinding (performance bias and detection bias) participantsLow riskIndividual participants not assessed in this trial.Blinding (performance bias and detection bias) investigatorsUnclear riskNot reported.Blinding (performance bias and detection bias) AssessorsUnclear riskNot reported.Incomplete outcome data (attrition bias) All outcomesLow riskAll houses were analysed. Individual participants not assessed.Selective reporting (reporting bias)High riskNon‐significant results not showed. \"The model also includes baseline survey in OT, PT, PC allocated houses when compared with LC ones, CDC light traps vs. aspirator collection, mixed houses vs. human houses, hamlets 2 vs. 1, and hamlets 3 vs. 1 (results not shown).\"Baseline measurementsHigh riskSignificantly higher numbers of *P. argentipes* males were noted during the baseline survey in PT (IRR: 5.70; P = 0.008) and OT (IRR: 4.63; P = 0.028) allocated houses than in LC houses. Larger numbers of females of *Sergentomyia*, mainly unfed, were observed in OT allocated houses (IRR: 1.96; P = 0.0480).Statistical adjustment for clusteringUnclear riskNo adjustment was done. However, the outcome was sandfly density and the analysis was conducted at the household level, which is the unit of randomization, thus removing any clustering effects.Other biasUnclear riskTrial authors did not provide a conflict of interest declaration.[@CD008736-bbs2-0005]MethodsTrial design: Cluster‐RCT.\
Unit of randomization: Urban sectors.\
Number of clusters: 12 (6 pairs) sectors (7636 inhabitants in 3000 households).\
Entomological data: monthly collection of phlebotomine sandflies from fixed indoors sites and from outdoors courtyards using 30 sticky traps and 20 (unspecified) light traps, assessed at one year.\
Clinical data collection: Follow‐up questionnaires and examinations were conducted every month between August 2004 and July 2005. All members of the participating households were examined. The presence or absence of CL ulcers was indicated on the forms.\
Length of follow‐up: 12 months.\
Analysis: Analysed at cluster level.ParticipantsIn each city, 6 urban sectors were selected based on the pre‐intervention epidemiological survey of disease in the area so that all sectors had a similar size and distribution of disease. Each sector in a pair was at least 2 km away from the other.\
**Endemic disease: CL caused by *L. tropica.***InterventionsOlyset® long‐lasting permethrin Insecticide‐treated nets (weigh of about 750 g and a surface area 14 m²).No ITNs.OutcomesNumber of new cases of CL, assessed at one year.Estimates of the density of the vectors.NotesCountry: Iran (cities of Sedeh and Shiraz).\
Trial dates: April 2004 to July 2005.\
Trial sponsor: This investigation received technical and financial support from the WHO Eastern Mediterranean Region (EMR), Division of Communicable Diseases (DCD) and the WHO Special Programme for Research and Training in Tropical Diseases (TDR): EMRO/DCD/TDR Small Grants Scheme for Operational Research in Tropical and Communicable Diseases.\
Sample size: Not calculated.\
Compliance assessment: Done. Health educational messages were disseminated to ensure participants\' compliance with the proper use of ITNs and that they did not use other methods of preventing phlebotomine sandflies. To ensure correct use of ITNs, 59 training sessions for families in the intervention group were carried out in schools and mosques. Pre‐intervention: Inhabitants of areas which most active cases of CL were recorded by health centres, were examined and forms were completed for each household during house‐to‐house visits. The interviewers examined scars and ulcers, recording cases that occurred during the 9 months before the interview. Students in all elementary schools were examined and questioned in the 2 cities.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low risk\"For each of the 6 pairs we used computer‐generated random numbers to allocate 1 sector to receive Olyset ITNs (intervention group) and the other sector to receive no nets (control group).Allocation concealment (selection bias)Unclear riskNot reported.Blinding (performance bias and detection bias) participantsUnclear riskNot reported.Blinding (performance bias and detection bias) investigatorsUnclear riskNot reported.Blinding (performance bias and detection bias) AssessorsUnclear riskNot reported.Incomplete outcome data (attrition bias) All outcomesLow riskNo information on loss of clusters. Loss to follow‐up of 11 participants (8/3818 in the intervention group and 3/3818 in the control group).Selective reporting (reporting bias)Low riskAll outcomes mentioned in the methods were reported in the results.Baseline measurementsUnclear riskNo baseline information. Questionnaire done, but not provided.Statistical adjustment for clusteringHigh riskNo statistical adjustment for clustering was made in the primary analysis of this cluster‐RCT.Other biasUnclear riskTrial authors did not provide a conflict of interest declaration.[@CD008736-bbs2-0006]MethodsTrial design: Paired RCT.\
Unit of randomization: Houses.\
Number of houses: 40.\
Entomological data collection: Sandflies were collected by CDC miniature light traps that were suspended from the ceiling at about 2 m from the ground floor and left overnight in the bedrooms of control and sprayed houses.\
Clinical data collection: Not done.\
Length of follow‐up: 79 days.\
Analysis: Analysed at house level.ParticipantsIncluded houses were made of mixture of mud and straw supported by a structure of sticks, called \"bahareque\" in the local colloquial language (24%), concrete blocks (26%) and wood (26%).\
**Endemic disease: CL caused by *L. braziliensis* and *L. mexicana.***InterventionsIRS using lambdacyhalothrin 10% water‐dispersible powder at a dosage of 25 mg/m². Insecticide application was made using a Hudson X‐Pert hand compression sprayer on the internal wall surface of the houses and on the lower surface of large furniture.Control group (not described).OutcomesEstimates of the density of the vectors assessed at 79 days.NotesCountry: Venezuela (El Ingenio).\
Trial dates: December 1996 to February 1997.\
Trial sponsor: STD Programme of the Commission of the European Communities (DG: XII: Science, Research and Development) (Contract no. TS3.CT.930247), the Consejo de Desarrollo Cientifico y Humanístico de la Universidad de Carabobo (CDC‐UC, Project FCS‐91‐044), and the Dirección de Malariologia y Saneamiento Ambiental, Ministerio de Salud y Asistencia Social, Maracay, Venezuela. One author of the trial (D. Campbell‐Lendrum) was supported by the Wellcome Trust.\
Sample size: Not calculated.\
Compliance assessment: Not reported.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskInsufficient details were reported about the method used to generate the allocation sequence. \"These were paired according to structure and randomly assigned to the control group (n = 20: B = 7, C = 6, and W = 7) or the group to be sprayed (n = 20: B = 7, C = 7, and W = 6)\".Allocation concealment (selection bias)Unclear riskNot reported.Blinding (performance bias and detection bias) participantsUnclear riskIndividual participants not assessed in this trial.Blinding (performance bias and detection bias) investigatorsUnclear riskNot reported.Blinding (performance bias and detection bias) AssessorsUnclear riskNot reported.Incomplete outcome data (attrition bias) All outcomesUnclear riskNo information if all houses were analysed. Individual participants not assessed.Selective reporting (reporting bias)Low riskAll outcomes mentioned in the methods were reported in the results.Baseline measurementsUnclear riskNo baseline information. Questionnaire done, but information not provided.Statistical adjustment for clusteringUnclear riskNo adjustment was done, however the outcome was sandfly density and the analysis was conducted at the household level, which is the unit of randomization, thus removing any clustering effects.Other biasUnclear riskTrial authors did not provide a conflict of interest declaration.[@CD008736-bbs2-0007]MethodsTrial design: Cluster‐RCT.\
Unit of randomization: Hamlets/neighbourhoods with 50 to 100 houses each.\
Number of clusters: 96, 24 per intervention arm.\
Entomological data collection: Cross sectional estimates of the density of the vectors using CDC light traps on 2 consecutive nights, in 5 randomly selected households in each intervention and control cluster.\
Clinical data collection: Not done.\
Length of follow‐up: 5 to 6 months.\
Analysis: Analysed at cluster level.ParticipantsVillages with a high reported incidence of VL in the past 3 years were selected.\
Socio‐economic conditions are described as comparable between sites but are not further described.\
**Endemic disease: VL caused by unknown *L. spp*.**InterventionsIRS: A field worker applied the insecticide to the interior walls of the house and cattle sheds, up to 6 ft high, targeting the cracks and crevices (in Bangladesh the exterior was also sprayed):Bangladesh: deltamethrin (target concentration 20 mg ai/m², Aventis Bayer);India: DDT 5% (target concentration 1 g/m², Hindustan Insecticide Limited).Nepal: alpha‐cypermethrine (target concentration 0.025 mg/m², Gharda Chemical Ltd.).Long‐lasting ITN: Distributed to all households (\"to cover all household members\").All sites: PermaNet® nets: Polyester with small mesh (156 holes/in²), impregnated with deltamethrin (55 mg/m²).EVM: Education and supervision of activities through trained community mobilizers to promote filling of cracks and crevices in houses and cattle sheds.Nepal and India: wall plastering with lime/mud mixture was promoted (lime was provided free of charge);Bangladesh: wall plastering with mud only (a token incentive was provided).Control: No specific vector control intervention.OutcomesMean number of phlebotomine sandflies per household per night at baseline and at 5 months post intervention.NotesCountry: India, Bangladesh and Nepal.\
Trial dates: November 2006 to April 2007.\
Trial sponsor: Special Programme for Research and Training in Tropical Diseases (TDR/WHO). The DDT for IRS in India was donated by the Hindustan Insecticide Limited and the LLINs (PermaNet®) for Bangladesh were donated by the Vestergaard‐Frandsen Company. The European Union FP6 INCODEV ‐ funded KALANET project supported the LLIN trial in India and Nepal‐BPKIHS.\
Sample size: Calculated.\
Compliance assessment: \"A spray field worker applied the insecticide to the interior (in Bangladesh also to the exterior) walls of the house and cattle sheds \... Quality control was done by the research team.\"***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskThe selection of clusters to include in the trial, the allocation of clusters to intervention arms, and the selection of households for entomological assessment are all described as \'random\' but no further details are given.Allocation concealment (selection bias)Unclear riskNot reported.Blinding (performance bias and detection bias) participantsLow riskIndividual participants not assessed in this trial.Blinding (performance bias and detection bias) investigatorsHigh riskInvestigators were not blinded.Blinding (performance bias and detection bias) AssessorsUnclear riskNot reported.Incomplete outcome data (attrition bias) All outcomesLow riskNo clusters were lost to follow‐up. Individual participants not assessed.Selective reporting (reporting bias)Low riskAll outcomes mentioned in the methods were reported in the results.Baseline measurementsLow risk\"Climatic conditions in the study areas were fairly uniform, with a low vector season from December to March due to lower temperatures. Socio‐economic conditions (including age structure, the number of people per household and the illiteracy rate) and disease awareness was comparable in each of the study sites\".\
Baseline measurements of mean phlebotomine sandflies per household were not significantly different at baseline.Statistical adjustment for clusteringLow risk\"Multilevel modelling with sample clusters (hamlet/neighbourhood) as the second level of clustering was applied. The Poisson‐regression procedure in STATA 10.1, with a robust sandwich estimator for clustering, was used in the analysis.\"Other biasHigh riskTrial authors declared no competing interests. The role of the founder is not clarified.[@CD008736-bbs2-0008]MethodsTrial design: Cluster‐RCT.\
Unit of randomization: Homestead with a single chicken shed.\
Number of clusters: 30 houses randomized to three arms.\
Entomological data collection: 5 CDC light traps in each cluster (3 in the house, 1 in the chicken shed and 1 in the dining hut) set from 18.00 to 06.15. Nine rounds of collections: 2 pre‐intervention and 7 post‐intervention; approximately 2 weeks apart.\
Clinical data collection: Not done.\
Length of follow‐up: 7 months.\
Analysis: Analysed at cluster level.Participants30 homesteads with chicken sheds were selected for the trial. After two pre intervention phlebotomine sandflies trapping rounds (4 weeks), each chicken shed of a group was randomly assigned to one of three treatments: spray, target or control (no insecticide).\
**Endemic disease: VL caused by *L. chagasi (L. infantum).***InterventionsIRS. Walls and roof, inside and out, of each chicken shed sprayed with lambdacyhalothrin (20 mg/m²; Icon 10% ME).ITS. Sheets treated with lambdacyhalothrin (20 mg/m²) installed 1 m from the roost.Control. No intervention\
(One homestead received all the interventions but we excluded it as it was not a randomized comparison).OutcomesGeometric mean abundance of *Lu. longipalpis* in the houses (all three traps combined), the chicken shed and the dining‐hut, measured at 3 and 7 months.NotesCountry: Brazil (conducted in 7 villages: Campinas, Pingo d\'Agua, Estrada, Vila Ceará, Vila da França, Vila Nova and Bacabau).\
Trial dates: November 1993 to June 1994.\
Trial sponsor: A research studentship from the Medical Research Council and a Chadwick Trust Travelling Fellowship, the Brazilian Fundaçao Nacional de Saude. Insecticide for the project was donated by Zeneca Saude Pública, Brasil. Facilities at the Instituto Evandro Chagas through BelBm Research Projects. Field expenses from the Brazilian Fundaçao Nacional de Saúde.\
Sample size: Not calculated.\
Compliance assessment: Not reported.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskInsufficient detail was reported about the method used to generate the allocation sequence. \"each chicken shed of a group was randomly assigned to one of three treatments: spray, target or control (no insecticide).\"Allocation concealment (selection bias)Unclear riskNot reported.Blinding (performance bias and detection bias) participantsLow riskIndividual participants not assessed in this trial.Blinding (performance bias and detection bias) investigatorsUnclear riskNot reported.Blinding (performance bias and detection bias) AssessorsUnclear riskNot reported.Incomplete outcome data (attrition bias) All outcomesUnclear riskNo information on loss of clusters. Individual participants not assessed.Selective reporting (reporting bias)Low riskAll outcomes mentioned in the methods were reported in the results.Baseline measurementsUnclear riskNo baseline information.Statistical adjustment for clusteringUnclear riskNo adjustment was done, however, the outcome was sandfly density and the analysis was conducted at the household level, which is the unit of randomization, thus removing any clustering effects.Other biasUnclear riskTrial authors did not provide a conflict of interest declaration. The role of the founder is not clarified.[@CD008736-bbs2-0009]MethodsTrial design: Cluster‐RCT.\
Unit of randomization: City sectors.\
Number of clusters: 14.\
Entomological data collection: Cross sectional estimates of the density of the vectors using light traps in the main room of 565 houses for 150 nights at baseline (pre‐intervention) and during the three months after the intervention (post‐intervention).\
Clinical data collection: Cross sectional questionnaire survey of 569 houses with 2913 inhabitants plus examination for past or current CL (pre‐intervention) at baseline and repeated at 12 months post‐intervention.\
Length of follow‐up: 12 months.\
Analysis: Analysed at individual (population) and cluster level (sector/houses).ParticipantsBaseline data on 2913 people living in 569 houses, follow‐up data on similar number. (The original sample size was 578 but 1.6% did not respond). The population was described as having moderate levels of poverty, 31% \< 15 years old, 9% \> 60 years old, average of 5 people per household, 21% were engaged in domestic activities, 21% were students, 13% were manual workers, self employed artisans, or secretaries, 7% were unemployed, 7% had an academic profession, and only 2% were farmers.\
Estimated annual incidence of leishmaniasis: 0.5% or above.\
**Endemic disease: CL caused by unknown *Leishmania* spp** (main vector: *Lu. youngi* and *Lu. ovallesi*).InterventionsITCs. The windows of all houses were covered with polyester curtains (mesh size: 0.05 mm), impregnated with lambdacyhalothrin (12.5 mg/m²; ICON 2.5CS, Syngenta, Basle) at baseline and at 6 months.Control. 7 sectors had unimpregnated curtains and 1 randomly selected sector had no curtains.  OutcomesNumber of new cases of CL assessed at 12 months.Mean number of houseflies per traps per night pre and post intervention.NotesCountry: Venezuela (Trujillo).\
Trial dates: January 2000 to August 2001.\
Trial sponsor: Funded by the European Commission (contract Alfa Programme 6­0011­9 and INCO­DEV IC18CT 980339). The insecticide was donated by Syngenta.\
Sample size: Not calculated.\
Compliance assessment: Not reported.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low risk\"For each of the seven matched pairs we randomly allocated one sector (using computer created random numbers) to the intervention group and the other to the control group\".Allocation concealment (selection bias)Unclear riskNot reported.Blinding (performance bias and detection bias) participantsHigh risk\"the population being "blind" towards the group allocation\". One sector did not receive unimpregnated curtains so would be aware of their allocation.Blinding (performance bias and detection bias) investigatorsUnclear riskNot reported.Blinding (performance bias and detection bias) AssessorsUnclear riskThis was not stated.Incomplete outcome data (attrition bias) All outcomesLow riskNo clusters were lost. The final number of participants were increased in 25 persons (see below). ITT analyses and dropouts per group and reasons described.Selective reporting (reporting bias)Unclear riskNot reported.Baseline measurementsUnclear riskOnly number cases (%) of CL and mean number of phlebotomine sandflies per traps captured, at baseline (other info not provided by groups).Statistical adjustment for clusteringHigh riskNo statistical adjustment for clustering was performed in the primary trial. However, sensitivity analysis was done at a range of ICCs in this review and it was concluded that if the ICC had been as high as 0.05, the CIs would have crossed over 1.\
Statistical analysis: The trial authors used EpiInfo, SPSS, and Stata v6 for analysis. Before the main analysis: Fisher\'s exact tests to compare cumulative incidence between intervention and control sectors for each pair. They used cumulative incidence rates of CL and the average number of flies per trap (house) for each sector as the units of analysis. They compared data at baseline and then at follow‐up between the intervention and control groups using a paired t test, weighting the data according to the sector size. They also used Wilcoxon\'s matched pairs test because the small number of pairs made it difficult to assess whether the underlying distribution of the differences was normal (necessary for the validity of the t test), and the Wilcoxon test does not require this assumption. Differences rather than ratios are presented as the estimates of effect because zeroes for the main outcome, CL, precluded the use of ratios.Other biasUnclear riskTrial authors declared no competing interests. The founders had no role in the trial.[@CD008736-bbs2-0010]MethodsTrial design: Cluster‐RCT.\
Unit of randomization: Hamlets.\
Number of clusters: 26 (13 intervention and 13 control clusters; 12,691 people).\
Entomological data collection: Done in [@CD008736-bbs2-0029], an excluded non‐randomized entomological study based in this trial.\
Clinical data collection:\
Cases of VL were double checked with patients\' records. Suspected people were examined by a physician who was blinded to the status of the cluster and tested with a rapid Kalazar Detect Rapid Test and classified as probable or certain VL. Asymptomatic infections were clinically followed up for a minimum of six months. Trained field workers carried out verbal autopsies on all deaths recorded during the trial. Two independent physicians ascertained cause of death.*L. donovani* infections as measured by seroconversion with the direct agglutination test at 12 and 24 months after the intervention, November to December 2007 and 2008, respectively. Seroconversion was considered only in people who had negative results on the direct agglutination test (≤ 1:800) in the baseline survey (or their first blood sample).\
Length of follow‐up: 30 months (from November 2006 to May 2009) for cases of VL and 12 to 24 months after the intervention for seroconversions.\
Analysis: Analysed at cluster level.ParticipantsClusters were paired on the basis of incidence of VL between 2003 and 2005.\
Eligibility criteria: In May 2006, they selected and included in the trial 26 (16 in India, 10 in Nepal) high incidence clusters out of 34 clusters with a high number of reported cases of VL (22 in India, 12 in Nepal) based on the following criteria:\
At least one case of VL in 2003, 2004, and 2005, indicating continuous *L. donovani* transmission.A minimum 0.8% average annual incidence rate of VL from 2003 to 2005.A population ranging from 350 to 1500 people.A minimum distance of 1 km between clusters.\
The 26 clusters were stratified by country (16 in India and 10 in Nepal) and population size (6 and 4, respectively, having over 710 residents) and then paired by previous average incidence rate of VL. Clusters in each pair were randomly allocated to group 1 or 2. The random selection of clusters into groups was undertaken in Excel (Microsoft), and the difference in the total number of cases of VL reported in the past three years between group 1 and 2 had to be less than 10%.\
All individuals living for at least six months a year in the clusters were eligible, but blood sampling was restricted to individuals aged over 2 years.\
**Endemic disease: VL caused by *L. donovani.***InterventionsLonglasting ITNs (PermaNet® 2.0, treated with deltamethrin 55 mg/m²; Vestergaard‐Frand‐ sen, Denmark; 75 denier, 25 holes/cm² coated fibres). Distributed in December 2006.No intervention as control. The control clusters were allowed to continue using any existing conventional strategies for personal protection. They were not provided with ITNs nor was the use of untreated nets promoted.OutcomesNumber of new cases of VL assessed at quarterly bases for 30 months.Presence of the parasite by seroconversion with the direct agglutination test assessed at 12 and 24 months after the intervention.NotesCountry: India (Muzaffarpur district) and Nepal (Sunsari, and Morang districts).\
Trial dates: November 2006 to May 2009.\
Trial sponsor: Funded by the European Union under its 6th Framework Program (INCODEV/Project 015374). Contract no INCO‐CT 2005‐01537, KALANET project.\
Sample size: Calculated.\
Compliance assessment: Done. \"In intervention clusters, 8920/9829 (91%) of the individuals slept regularly (that is, over 80% of the nights) under a treated net. Those observations were confirmed by an additional acceptability survey (V Vanlerberghe, personal communication, January 2010). The use of untreated nets in the control group was variable; 7012/9981 (70%) used a bed net at least once during the trial but only 2978/9981 (30%) used it regularly throughout the year as most of the households did not have enough nets for all their members.\"***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low risk\"The intervention was then randomly allocated to one of the groups by tossing a coin in the presence of observers.\"Allocation concealment (selection bias)Unclear riskNot reported.Blinding (performance bias and detection bias) participantsUnclear riskThis was not stated.Blinding (performance bias and detection bias) investigatorsUnclear riskThis was not stated.Blinding (performance bias and detection bias) AssessorsLow risk\"All clinically suspected cases detected during the trial were classified as probable or certain visceral leishmaniasis by a clinician who was blinded to the status of the cluster\".Incomplete outcome data (attrition bias) All outcomesLow riskNo clusters were lost to follow‐up. Analyses and dropouts per group and reasons described. The proportion of people lost to follow‐up (not present or with one or no blood sample) was slightly higher in the control group (21%, (644 +1466)/9981) than in the intervention group (19%, (545+1347)/9829). But the characteristics of the participants lost to follow‐up in both groups were similar (mean age 22 v 23, males 62% v 63%, mean socioeconomic status 2.0 v 2.2, in intervention and control groups respectively).Selective reporting (reporting bias)Low riskAll outcomes mentioned in the methods were reported in the results.Baseline measurementsLow riskYes (table). Intervention and control groups were well balanced at individual and cluster levels, but the prevalence of positive results on the direct agglutination test at baseline in India was almost twice as high as in Nepal, despite the previous annual incidence of VL being similar.Statistical adjustment for clusteringLow riskData were analysed at the cluster level. No adjustment for clustering needed as analysis was done at the cluster level.Other biasLow riskTrial authors declared no competing interests. The trial founder had no role in the trial design, data collection and analysis, interpretation or reporting of this work, or the decision to submit the work for publication. Competing interests: All authors completed the Unified Competing Interest form and declared: \"no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work\".[@CD008736-bbs2-0011]MethodsTrial design: Cluster‐RCT.\
Unit of randomization: Blocks of 10 houses.\
Number of clusters: 957.\
Entomological data collection: Not done.\
Clinical data collection: Cross‐sectional questionnaire survey of all houses and examination for current or past CL pre‐intervention and at 8, 10 and 15 months post‐intervention.\
Length of follow‐up: 15 months.\
Analysis: Analysed at cluster level.ParticipantsThe population is described as being \'previously lower middle‐class\' in a suburb of Kabul, with houses mostly made from mud or brick. There was no evidence of prior bednet use in the area. The mean age, sex distribution, and prevalence of old and current CL was similar between groups at baseline.\
**Endemic disease: Anthroponotic CL caused by *L. tropica*.**InterventionsIRS. Sprayed with 30 mg/m² lambdacyhalothrin.ITNs. Family sized polyester nets (156 holes per square inch) impregnated with 0.5 g/m² permethrin.ITS. Families supplied their usual bedsheet (usually a chaddar ‐ head covering clothes ‐ or a similar piece of cotton cloth), which was impregnated with permethrin (1 g/m²: Imperator 25 EC, Zeneca) plus instructions not to wash it.Control. Households were offered a 1O‐s aerosol spray using a 1:50 solution of permethrin delivered from a knapsack motorized aerosol into the centre of their living and sleeping rooms. The estimated deposition rate was \< 0.5 mg/m².OutcomesNumber of new CL cases at 8, 12 and 15 months.NotesCountry: Afghanistan (Karte‐Naw area of Kabul).\
Trial dates: May 1997 to August 1998.\
Trial sponsor: Norwegian Church Aid, the European Commission (ECHO), WHO/UNDP/WB Special Programme for Research and Training in Tropical Diseases (project no. 960662), the Department for International Development (UK), and HealthNet International.\
Sample size: Calculated.\
Compliance assessment: Done. \"All the trial houses were re‐visited and the household head (mother or father) was asked 3 questions: \'have you noticed less biting by insects this year?\', \'are you generally satisfied with the (intervention)?\' and \'would you be willing to pay for this service in the future?\'. A simple yes‐no response was recorded. Direct observation of bednet compliance or sleeping habits was not socially acceptable\".***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskInsufficient detail was reported about the method used to generate the allocation sequence. \"interventions were randomly allocated to houses within each block\".Allocation concealment (selection bias)Unclear riskNot reported.Blinding (performance bias and detection bias) participantsHigh riskParticipants were not blinded.Blinding (performance bias and detection bias) investigatorsHigh riskInvestigators were not blinded.Blinding (performance bias and detection bias) AssessorsLow riskOutcome assessors were blinded. \"Survey workers were blinded as to the intervention received by households, having been provided with a survey form that was blank except for the address, and were instructed to ask respondents not to reveal the type of intervention during the interview.\"Incomplete outcome data (attrition bias) All outcomesHigh riskNo information on loss of clusters. ITT analysis was not used. Loss to follow‐up of 45% of participants, 7565 persons in total. although they did not specify the group this people belong.Selective reporting (reporting bias)Low riskAll outcomes mentioned in the methods were reported in the results.Baseline measurementsLow riskBaseline information: participants mean of age, % of male and female, % of people with CL active or past, and location of lesions.Statistical adjustment for clusteringLow riskData were cluster adjusted using a random‐effects logistic regression model.Other biasUnclear riskTrial authors did not provide a conflict of interest declaration.[@CD008736-bbs2-0012]MethodsTrial design: Cluster‐RCT.\
Unit of randomization: Villages.\
Number of clusters: 20 villages (3631 people).\
Entomological data collection: Not performed.\
Clinical data collection:\
Participants were examined for scars or active skin lesions suspected to be American CL, using clinical criteria defined in a trial ([@CD008736-bbs2-0061]).The leishmanin skin test was applied to detect prior *Leishmania* infection. The status of community participation in each village was assessed and quantified using a community participation unpublished score.\
Length of follow‐up: 12 months.\
Analysis: Analysed at cluster level.ParticipantsVillages were paired according to prevalence of leishmanin skin test positive in children \< 5 years old, number of inhabitants, and community participation score. One village in each pair was randomly assigned to receive the intervention; the other remained as a control.\
**Endemic disease: CL caused by *L. braziliensis* and *L. panamensis.***InterventionsNew polyester bed nets (11.6 m² and 35 holes per cm²) were provided to all the participants after being impregnated with K‐Othrine E‐25® (deltamethrin). Two bars of the repellent Nopikex (20% DEET and 0.5% permethrin) were delivered to each residence. Tree trunks that could serve as resting sites for phlebotomine sandflies and were located \< 50 m from an inhabited residence were painted with whitewash to a height of 1.5 m from the ground.Control villages did not receive any of the studied interventions, but like the intervention villages, they were subject to active surveillance and case management of American CL cases. Both for 12 months approximately. Every three months the bed nets were impregnated, additional repellent supplied, and the tree trunks repainted.OutcomesNumber of new CL cases at 12 months.Presence of the parasite by leishmanin skin at the beginning of the trial and at 12 months.NotesCountry: Colombia (Tumaco, Nariño department).\
Trial dates: October 1994 to June 1997.\
Trial sponsor: WHO Research Training Grant and supported by the International Development Research Centre of Canada, IDRC file 92‐0223‐01. It included an educational programme designed and implemented by the Centro de Investigaciones Multidisciplinarias en Desarrollo (CIMDER) that included information about American CL, its mode of transmission and how to use the different preventive measures accompanied the preventive measures.\
Sample size: Not calculated.\
Compliance assessment: \"Frequency of bednet use was high and consistent during the study. Among the participants who were interviewed during the first and second monitoring visits, 93% and 96% respectively reported sleeping under the bednet every night. This was confirmed during the two unannounced visits to the residences, where approximately 85% of the bednets were in use by the participants. Because there was not enough variation we could not evaluate dose effect for bednet use. Four of the intervention villages only had three impregnation sessions due to logistical constraints. Complete adherence to the impregnation schedule, defined as the percentage of bednets that received all the impregnations (4 or 3 depending on the village), varied among villages (17%‐100%) (data not presented). Very few participants abstained from washing their bednets between two impregnations. Seventythree percent of the participants reported they washed the bednets three or more times during that period (approximately 3 months).\"***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low risk\"Randomization was performed using a lottery system.\"Allocation concealment (selection bias)High risk\"Randomization\...was carried out with the participation of delegates from the 20 villages.\"Blinding (performance bias and detection bias) participantsUnclear riskNot reported.Blinding (performance bias and detection bias) investigatorsUnclear riskNot reported.Blinding (performance bias and detection bias) AssessorsUnclear riskNot reported.Incomplete outcome data (attrition bias) All outcomesUnclear riskNo clear information on loss of clusters (\"four of the intervention villages only had three impregnation sessions due to logistical constrains\"). ITT analysis was not used. There were losses to follow‐up, but the drop‐outs were excluded from the beginning of the trial to analyse the results. Control group: thirteen persons excluded because they moved to an intervention village during the follow‐up period. No movements in the opposite direction were documented. Absence from the village on the days of the post‐intervention exam was somewhat more common in the intervention group (no numbers).Selective reporting (reporting bias)Low riskAll outcomes mentioned in the methods were reported in the results.Baseline measurementsHigh riskIn general, the trial groups were comparable in the distribution of behavioral and occupational risk factors, but differed in the distribution of those factors related with the residence and the village. Residences in the control group were more likely to be located at the periphery, close to the forest, have roof made of thatch, have incomplete external walls and have more animals. Also, control villages had lower community participation scores. On the other hand, villages in the intervention group had a greater prevalence of infection in children \< 5 years old, had a larger number of inhabitants and had a slightly higher number of males.\
Characteristics of the residence (distance to the forest \< 50 m, and roof made of thatch) and the village (prevalence of infection in children \< 5 years old, and community participation score \< 50) were strongly associated with American CL in this setting. Several behavioural and occupational activities were moderately associated with infection, as were characteristics of the residence (roof made of thatch and walls made of bamboo) and the village (prevalence of infection in children \< 5 years old, and community participation score \< 50).Statistical adjustment for clusteringLow riskGeneralised estimating equations were used to adjust for clustering within villages using an exchangeable correlation matrix.Other biasLow riskTrial authors declared no competing interests.[@CD008736-bbs2-0013]MethodsTrial design: Double‐blind, placebo‐controlled RCT.\
Unit of randomization: A soldier.\
Number of participants: 286 soldiers (143 in each group).\
Entomological data collection: Not done.\
Clinical data collection: Medical examination. Definitive diagnosis was made by staining a lesion smear with Giemsa and with antileishmanial monoclonal antibodies for detecting amastigotes. If not seen the lesion was biopsied and stained for amastigotes and cultured for promastigotes. If promastigotes detected, they were identified to the species level with the use of isoenzyme electrophoresis.\
Length of follow‐up: 12 weeks.\
Analysis: Analysed at individual level.ParticipantsMembers of the Colombian army scheduled for patrol in the leishmaniasis‐endemic area of Magdalena Medio with no history of having leishmaniasis and no current signs of infection.\
**Endemic disease: CL caused by *L. panamensis*.**InterventionsPermethrin‐impregnated uniforms (shirt, undershirt, pants, socks and hat; were soaked in a solution containing 1 sachet (15 mL) of permethrin (gift of AgrEvo, UK; cis : trans isomer ratio 25:75) per 2 L of water for 2 min, then air‐dried for 2 to 4h, resulting in a permethrin concentration of 850 mg/m^2^ of clothing).Control uniforms (shirt, undershirt, pants, socks and hat; were soaked in water that did not contain permethrin).OutcomesNumber of new cases of leishmania, assessed at 12 weeks.Adverse effects (two participants in the intervention group reported irritation and pruritus).NotesCountry: Colombia.\
Trial dates: Unknown.\
Trial sponsor: AB Foundation, Chevy Chase, Maryland, USA, and Rousel Uclaf/Sova de Colombia S.A., Santafe de Bogota, Colombia.\
Sample size: Not calculated.\
Compliance assessment: Not done. Adherence to instructions (how to use and wash uniforms) was not monitored. \"Because the purpose of the study was to determine the efficacy of permethrin impregnation under conditions of normal duty, adherence to these instructions was not monitored\"***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskInsufficient detail was reported about the method used to generate the allocation sequence. \"All troops were randomised\".Allocation concealment (selection bias)High riskNot reported.Blinding (performance bias and detection bias) participantsUnclear riskParticipants were blinded. \"The uniforms were distributed in such a way that the participants (soldiers)\...did not know which uniforms had been treated with permethrin\".Blinding (performance bias and detection bias) investigatorsUnclear riskInvestigators were blinded. \"The uniforms were distributed in such a way that\...the medical attendants did not know which uniforms had been treated with permethrin\".Blinding (performance bias and detection bias) AssessorsUnclear riskThis was not stated.Incomplete outcome data (attrition bias) All outcomesLow riskITT analysis was used. No dropouts.Selective reporting (reporting bias)Low riskAll outcomes mentioned in the methods were reported in the results.Baseline measurementsUnclear riskBaseline information: participants were male soldiers.Statistical adjustment for clusteringLow riskNot applicable as this trial was individually randomized.Other biasUnclear riskTrial authors did not provide a conflict of interest declaration.[@CD008736-bbs2-0014]MethodsTrial design: Cluster‐RCT.\
Unit of randomization: Geographic area.\
Number of clusters: 40 geographic areas.\
Entomological data collection: Not done.\
Clinical data collection: Conversion of the Montenegro skin test (MST) at 18 months of follow‐up.\
Length of follow‐up: 18 months.\
Analysis: Analysed at cluster level.ParticipantsTen localities in 7 neighbourhoods of the city of Teresina (Brazil) were divided into blocks, each containing an average of 60 residences. For each locality, 4 blocks were selected to minimize the risk of cross‐contamination of interventions. Eligible participants were residents of selected blocks aged 1 year or above with no history of VL. The 40 geographic areas (blocks) randomly allocated to the 4 types of interventions (697 subjects MST‐).\
**Endemic disease: VL caused by *L. chagasi (L. infantum).***InterventionsSpraying households and residential annexes with insecticide.Elimination of infected dogs.Combination of spraying and eliminating infected dogs.No intervention.\
Description of spraying: performed according to the routine of the VL Control Program of the Zoonosis Control Center of the Teresina City Health Department. Interventions were delivered in the selected blocks every 6 months, for three times, beginning just after each household visit. The elimination of infected dogs was decided if indirect immunofluorescence test was more or equalled 1:40.OutcomesCases of infection by L. infantum at 18 months determined by conversion of the MST (MST‐ at the beginning) or diagnosis of active VL.NotesCountry: Brazil (Teresina, Itararé quarter).\
Trial dates: January 2004 to December 2006.\
Trial sponsor: Funded by Health Surveillance Unit from the Brazilian Ministry of Health. One author was partially funded by the Brazilian Research Council (CNPq 306267/2010‐1 and 202088/2012‐0). The founders had no role in trial design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have declared that no competing interests exist.\
Sample size: Calculated.\
Compliance assessment: Not reported.***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low risk\"Allocation was performed as follows: (a) for each locality, a number was assigned to each block, (b) the intervention schemes were ordered as described above, and (c) using the command \"sample\" in Stata, the first block sampled was allocated to intervention (i), the second to intervention (ii) and so on. At the end, each intervention scheme was allocated to a total of ten blocks throughout the ten selected localities.\"Allocation concealment (selection bias)Unclear riskNot reported.Blinding (performance bias and detection bias) participantsUnclear riskNot reported.Blinding (performance bias and detection bias) investigatorsUnclear riskNot reported.Blinding (performance bias and detection bias) AssessorsUnclear riskNot reported.Incomplete outcome data (attrition bias) All outcomesUnclear riskNo information on loss of clusters. \"Losses to follow‐up varied from 35.7% to 40.7% between intervention groups, but no statistically significant difference was found comparing each intervention group with the control group (all P values \>0.3).\"Selective reporting (reporting bias)High riskThe trial authors\' original plan was to use IFAT test at 6 and 12 months, but due to operational problems, data on IFAT results were not considered valid for the analysis, and serology was not used as a marker of infection in the trial. Problems with serology were poor sensitivity and reproducibility (\"For instance, among the 951 subjects for which an IFAT result was available at baseline, only 16 (1.68%) were positive\"). The authors decided not to use IFAT results in the trial and relied on conversion of the MST at 18 months of follow‐up as the only outcome measure, since no clinical cases of VL were detected among the studied population.Baseline measurementsUnclear riskA table shows the distribution of selected baseline socio‐demographic and environmental characteristics for each intervention group. The dog culling groups showed \"higher mean years of living in the residence and a smaller percentage of households with a chicken shed in the peri‐domestic environment as compared to the control group (P \< 0.015 and P \< 0.046, respectively). No other statistically significant difference with any variables or groups was detected.\"Statistical adjustment for clusteringLow risk\"Using Poisson population‐average models from generalized estimating equations with robust variance, an exchangeable correlation model, and designating each block as the clustering level\".Other biasLow riskTrial authors declared no competing interests. The trial was funded by Health Surveillance Unit from the Brazilian Ministry of Health. GLW was partially funded by the Brazilian Research Council (CNPq 306267/2010‐1 and 202088/2012‐0). The founders had no role in trial design, data collection and analysis, decision to publish, or preparation of the manuscript.

Characteristics of excluded studies \[ordered by study ID\] {#CD008736-sec2-0028}
===========================================================

StudyReason for exclusion[@CD008736-bbs2-0015]Laboratory and field‐exposure (with pair of volunteers) experiments (no assessment in natural conditions).[@CD008736-bbs2-0016]Cluster quasi‐RCT: assignment to each treatment to the houses was made randomly on the first night and then rotated sequentially from house to house.[@CD008736-bbs2-0017]Duplicate of [@CD008736-bbs2-0001].[@CD008736-bbs2-0018]This study focused on general mosquito bites, not leishmaniasis.[@CD008736-bbs2-0019]Only preferences between two different kinds of LLIN.[@CD008736-bbs2-0020]Entomological study of cows placed under different nets in cattle sheds.[@CD008736-bbs2-0021]Some houses within each village were allocated on the basis of pre‐intervention sandfly or epidemiological data.[@CD008736-bbs2-0022]Cluster quasi‐RCT: villages were randomly assigned to the intervention or control group; subsequent pairs were then assigned alternately to either the intervention or control.[@CD008736-bbs2-0023]Cluster quasi‐RCT: villages were randomly assigned to the intervention or control group; subsequent pairs were then assigned alternately to either the intervention or control.[@CD008736-bbs2-0024]Cluster quasi‐RCT: authors randomly selected 10 houses from a village for the intervention group, but for the control group they used 5 houses separated from the intervention houses by approximately 450 m.[@CD008736-bbs2-0025]Only an assessment about prevention methods used against leishmaniasis in 9 kala‐azar endemic districts.[@CD008736-bbs2-0026]Treatments were randomly performed in the corresponding districts but all households enrolled in district Shaghayegh received ITNs and ITCs; Households in district Honar received non‐impregnated bed nets and curtains and district Vakilabad was the control area.[@CD008736-bbs2-0027]Only one cluster in each group.[@CD008736-bbs2-0028]Evaluation about knowledge and practices against leishmaniasis. [@CD008736-bbs2-0029]Based on an included paired cluster‐RCT ([@CD008736-bbs2-0010]) were each group were randomly allocated to ITNs or control, in this excluded trial the design was not random as mentioned in the paper. \"Out of the 26 KALANET clusters, 3 intervention and 3 control clusters in each country were selected for the entomological trial on the basis of year round accessibility and VL incidence rates. 13 clusters were initially assessed (6 in India and 7 in Nepal) and one was finally excluded in Nepal. Being a subset of the KALANET clusters, the 12 selected clusters for the entomological trial were not necessarily paired.\"[@CD008736-bbs2-0030]It is not as trial. It is an assessment on the impact of a basic health plan for preventing CL in rural areas of Colombia.[@CD008736-bbs2-0031]Allocation not randomized, \"the villages were randomly assigned as intervention or control villages based on the prevalence and size of the villages. H and SN were considered an intervention villages, TS and KS as control villages.\"[@CD008736-bbs2-0032]Unclear trial design. \"Three villages (called Komshecheh, Aliabad‐Mollaali, and Habibabad) were selected randomly in the rural district of Borkhar, Isfahan province, central Iran. Then, in each village, 168 households near each other with similar prevalence (2.1‐ 2.7% for lesions and 70.4‐81.2% for scars) were recruited to the study. Treatments were randomly performed in corresponding villages. All households enrolled in Habibabad received impregnated bed nets and curtains (IBs and ICs); Aliabad‐Mollaali, non‐impregnated bed nets and curtains (NIBs and NICs) and Komshecheh was decided to be the control area.\"

Characteristics of ongoing studies \[ordered by study ID\] {#CD008736-sec2-0029}
==========================================================

[@CD008736-bbs2-0033]Trial name or titleReplacement of Insecticides to Control Visceral LeishmaniasisMethodsAllocation: randomized, endpoint classification: efficacy study, intervention model: factorial assignment, masking: open label, primary purpose: preventionParticipants[Inclusion criteria]{.ul}\
Household head who agree to participate in the study.\
[Exclusion criteria]{.ul}\
Household head who does not agree to participate in the study.Interventions[Interventions]{.ul}\
A: IWFPL: Indoor house walls and floors will be plastered with lime (a traditional method known in the study areas) including treatment of outdoor breeding places with lime and bleaching powder to inhibit sandfly breeding;\
B: IDWL: Install durable wall lining containing deltamethrin to kill immature stage and as well as adult phlebotomine sandflies;\
C: ITN: Impregnation of existing bednets available in the community with slow release insecticide, deltamethrin.\
[Control intervention]{.ul}\
D: Control group, no intervention.Outcomes[Primary outcome]{.ul}\
Measurement of efficacy of interventions\
[Secondary outcome]{.ul}\
Estimation of intervention costs and its acceptability\
For all outcomes, assessments were at 12 months.Starting dateMay 2012Contact informationDinesh Mondal, MBBS, MD, PhD Telephone: +8801712027091 Email: din63d\@icddrb.orgNotes

UG was a link with the editorial base and coordinated contributions from review co‐authors. AF and MP searched for trials (including developed a search strategy, obtained papers, contacted authors, investigators or drug companies). CE, AF, UG, MP and IV selected trials for inclusion and extracted data from included trials. MP, UG and DS entered data into [@CD008736-bbs2-0056]. TE, DS and UG performed analyses. AF, UG, MT, CE, DS, JA interpreted the data. All review authors drafted the final review. JA and IV, the expert representatives, focused on relevance and applicability of the Cochrane Review.
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None known (All).

[^1]: Editorial Group: Cochrane Infectious Diseases Group.

[^2]: ^1^Downgraded by 1 for serious risk of bias: Trials are at high or unclear risk of selection bias and reporting bias. ^2^No serious inconsistency: Reductions in sandfly abundance were seen after IRS spraying in all four trials (compared to control areas). ^3^No serious indirectness: The trials used insecticides shown to be effective in the trial area. Trials were from India, Bangladesh, Nepal, Venezuela and Brazil. ^4^The assumed risk of CL over 12 months follow‐up is taken from the control group in [@CD008736-bbs2-0011]. This trial was conducted in Afghanistan from 1997 to 1998. ^5^No serious indirectness: This single trial was conducted in urban areas of Afghanistan using lambdacyhalothrin at a target rate of 30 mg/m². Further trials from different settings would increase confidence in this result. ^6^Downgraded by 1 for serious imprecision: The 95% CI is wide and includes clinically important effects and no real difference.

[^3]: ^1^Three RCTs evaluated vector density, but one did not present before and after data and only stated the difference was statistically significant. ^2^Downgraded by 1 for serious risk of bias: Trials are at high or unclear risk of selection bias and reporting bias. ^3^Downgraded by 1 for serious inconsistency: [@CD008736-bbs2-0002] reports a statistically significant difference in total vector numbers over 12 months follow‐up, [@CD008736-bbs2-0005] reports statistically significant reduction but did not provide data. [@CD008736-bbs2-0007] found no difference in mean number of vectors per household. ^4^No serious indirectness: [@CD008736-bbs2-0002] distributed PermaNet® 2.0 to all households in trial sites in Bangladesh, [@CD008736-bbs2-0005] distributed Olyset® in Iran, and Joshi 2009 distributed PermaNet® to households in India, Bangladesh and Nepal. ^5^The assumed risk of CL over 12 months follow‐up is taken from [@CD008736-bbs2-0011] which contributed 99.5% of weight to this analysis. This trial was conducted in Afghanistan from 1997 to 1998. ^6^No serious indirectness: These two trials were conducted in urban areas of Iran (Olyset® nets), and Afghanistan (family size bednets impregnated with 0.5 g/m² of permethrin). The findings would be expected to apply to other endemic areas. ^7^No serious inconsistency: The two trials found similar effects. However, once adjusted for clustering the result was not statistically significant in the trial from Iran. ^8^The assumed risk of VL over 2 years months follow‐up is taken from the control group of [@CD008736-bbs2-0010] ‐ a study conducted in India and Nepal in 2006/09. ^9^No serious indirectness: This single trial was conducted in two areas (India and Nepal) using PermaNet® 2.0. ^10^Downgraded by 1 for serious imprecision: This trial found no difference between ITNs and control areas. However the 95% CI remains wide and includes the possibility of clinically important effects.

    ^11^Downgraded by 1 for serious indirectness: There are single trials from particular geographical areas.

[^4]: ^1^Downgraded by 1 for serious risk of bias: Trials were at high or unclear risk of selection bias and reporting bias. ^2^Downgraded by 1 for serious indirectness: There are single trials from particular geographical areas. The result may not be applicable elsewhere. Polyester curtains were impregnated with 12.5 mg/m2 lambdacyhalothrin at baseline and after 6 months. ^3^No serious imprecision: At 12 months post intervention vector density was substantially lower in the intervention group (P \< 0.001) ^4^The control group risk of CL in [@CD008736-bbs2-0009] was 89 per 1000 people. For consistency with other \'Summary of findings\' tables we used an assumed risk of 52 per 1000, which was taken from [@CD008736-bbs2-0011]. ^5^No serious imprecision: At 12 months post intervention, no CL cases had been reported in the intervention areas, compared to 148 in control areas.

[^5]: ^1^One trial evaluated the effects of hanging ITS near to a chicken shed. ^2^Downgraded by 1 for serious risk of bias: Trials are at high or unclear risk of selection bias and reporting bias. ^3^Downgraded by 2 for very serious indirectness: This is a single trial and does not directly assess the effects of ITS. ^4^The trial authors state that \"the abundance in sheds was approximately 50% below that expected on the first day falling to about 80% at week 12 ‐ the only time the difference was statistically significant\". ^5^The assumed risk of CL over 12 months follow‐up is taken from the control group of [@CD008736-bbs2-0011]. This trial was conducted in Afghanistan from 1997 to 1998. ^6^Downgraded by 1 for serious indirectness: This trial was conducted in urban areas of Afghanistan using ITS treated with permethrin (1 g/m²). Further trials from different settings would increase confidence in this result.

[^6]: ^1^The risk of CL in the control groups was 7% in Iran ([@CD008736-bbs2-0001]) and 13% in Colombia ([@CD008736-bbs2-0013]). To be consistent with the other \'Summary of findings\' tables, we presented an assumed risk of 5.2%. ^2^Downgraded by 1 for serious risk of bias: Trials are at high or unclear risk of selection bias and reporting bias. ^3^No serious inconsistency: Although, one trial reported a statistically significant difference and one does not, this is likely related to the low CL incidence in the trial finding no difference. ^4^No serious indirectness: In both Iran and Colombia, soldiers were randomized to wear permethrin treated uniforms (concentration of 850 mg/m²) or standard uniforms. ^5^Downgraded by 1 for serious imprecision: The 95% CI of the overall effect is wide and includes clinically important effects and no difference.

[^7]: ^1^Downgraded by 1 for serious indirectness: This trial was conducted in urban areas of Colombia using a multifaceted intervention with ITNs, bars of insect repellent and permethrin painted trunks. Further studies with other combination of interventions and different settings would increase confidence in this result. ^2^Downgraded by 1 for serious risk of bias: the trial is at high or unclear risk of selection bias and reporting bias. ^3^Downgraded by 1 for serious imprecision: The 95% CI of the overall effect is wide and includes clinically important effects and no difference.

[^8]: ^1^Downgraded by 1 for serious risk of bias: Trials are at high or unclear risk of selection bias and reporting bias. ^2^Downgraded by 1 for serious inconsistency: [@CD008736-bbs2-0002] reports a statistically significant difference in total vector numbers over 12 months follow‐up, [@CD008736-bbs2-0007] found no difference in mean number of vectors per household. ^3^No serious indirectness: The trials used insecticides shown to be effective in the trial area. Trials were from India, Bangladesh and Nepal.

    ^4^Downgraded by 1 for serious indirectness: There is a single trial from a particular geographical area. ^5^No serious indirectness: This trial was conducted in urban areas of Afghanistan using lambdacyhalothrin at a target rate of 30 mg/m². Further studies from different settings would increase confidence in this result. ^6^Downgraded by 1 for serious imprecision: The 95% CI is wide and includes clinically important effects and no real difference.

[^9]: Based on [@CD008736-bbs2-0063]. Abbreviations: CL: cutaneous leishmaniasis; VL: visceral leishmaniasis; PKDL: post kala‐azar dermal leishmaniasis.

[^10]: Abbreviations: BRA = Brazil; IRN = Iran; VEN = Venezuela; AFG = Afghanistan; COL= Colombia; ICC = intra‐cluster correlation co‐efficient; SE = standard error; RR = risk ratio; OR = odds ratio. ^1^We calculated the ICC by comparing the cluster‐adjusted SE with the unadjusted SE to calculate the design effect (DE) and then using the formula: DE = 1+(M‐1)\*ICC where M=mean cluster size. ^2^We chose the ICC value by looking for the trial with the most similar size of clusters and number of clusters.

[^11]: Abbreviations: VEN = Venezuela; BRA = Brazil; BGD = Bangladesh; IRS = indoor residual spraying; RR = risk ratio).

[^12]: Adapted from [@CD008736-bbs2-0011]. Age distribution of new CL cases among the non‐immune participants at the end of the trial. Acording to trial authors, the age distribution of new cases was not significantly different between the intervention groups (P = 0.48).

[^13]: Abbreviations: IRN = Iran; BGD = Bangladesh; ITNs = insecticide treated nets; RR = risk ratio).

[^14]: Abbreviations: IND = India; CDC = Centers for Disease Control and Prevention.

[^15]: Abbreviations: VEN = Venezuela; ITNs = insecticide treated nets; ITCs = insecticide treated curtains.

[^16]: Abbreviations: BRA = Brazil: ITS = insecticide treated sheet.

[^17]: Abbreviations: BGD = Bangladesh; EVM = environmental modification.

[^18]: Abbreviations: BGD = Bangladesh; IRS = indoor residual spraying; ITNs = insecticide treated nets.

[^19]: Abbreviations: BRA = Brazil; IRS = indoor residual spraying; ITS = insecticide treated sheets.

[^20]: Abbreviations: IRS = indoor residual spraying; EVM = environmental modification.

[^21]: Abbreviations: BGD = Bangladesh; ITNs = insecticide treated nets; EVM = environmental modification.
